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ABSTRACT
Development and Characterization of Monoclonal Antisperm
Antibodies: Potential for Contraception
Dilrowshan H. Hague
Old Dominion University
Eastern Virginia Medical School
May, 1991
Directors:

Drs. Nancy J. Alexander and Patricia A. Pleban

There is an expressed need to develop a greater variety
of safe contraceptive methods which would find acceptance
worldwide, particularly in developing countries.

Immuniza

tion against spermatozoa might be such a method as judged by
the accumulated evidence from studies on human females and
in a number of female animal species.
Two extraction techniques were used for sperm membrane
antigen isolation.

The first technique involved NP-40

detergent for antigen extraction from human motile sperm and
the second technique employed homogenized human testis for
antigen extraction.

Using these immunogens, sperm membrane-

specific monoclonal antibodies (MAbs) were developed.

When

these antisperm MAbs were subjected to evaluation against an
extensive panel of human tissues, no cross-reactivity to
somatic tissues was observed, but staining was seen on sperm
cells in testis, caput- and cauda epididymis, and vas defer
ens.

Four of these antisperm MAbs were against epididymal

antigens, three were against seminal vesicle factors, and
seven were against testis specific antigens.

These
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evaluations indicated sperm specificity of these antibodies,
fulfilling one of the important criteria for contraceptive
vaccine development set forth in a World Health Organization
(WHO) monoclonal antibody workshop report.

The results of

immunofluorescence (IF) and immunochemical staining (ICS)
studies on methanol-fixed sperm indicated that these anti
bodies recognized antigens on the plasma membrane overlaying
different regions of the sperm, i.e., acrosome, postacrosome, equatorial, midpiece, and tail.

When these anti

sperm MAbs were tested on fresh, capacitated, and acrosome
reacted spermatozoa, a differential reactivity with fresh
sperm as compared to acrosome reacted sperm was observed.
The wide species cross-reactivity of these antisperm anti
bodies indicated shared antigens in these species, raising
the possibility of employing experimental animal models to
test contraceptive vaccines.
These antisperm MAbs demonstrated the multiplicity of
antigens having a role in the process of fertilization.
Eight of these antisperm MAbs were able to inhibit at least
one sperm functional test in vitro, which satisfied another
criterion for immunocontraceptive vaccine development.
Since one MAb (DH22) was capable of binding to the acrosomal
cap region of acrosome reacted sperm, this MAb could be used
as a marker to identify acrosomal reacted sperm among the
different matured stages found in a sperm population.
Purification and biochemical characterization of these sperm
antigens to which these antisperm MAbs were directed, would
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be of interest to better understand their immunocontraceptive potential.
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CHAPTER 1

INTRODUCTION

The world population is increasing at an alarming rate.
As we enter the 1990s, excessive population growth continues
worldwide.

The world population will increase to about ten

billion in the 21st century and ninety-five percent of this
global population growth is concentrated in developing
countries (U.N., 1984).

This continued growth means a

severe scarcity of the available meager resources with a
subsequent lowering of the standard and quality of living in
these already poor countries.

In light of the above, a

continued search for safe, acceptable and reliable means of
fertility regulation must be maintained and accelerated.
The following is a list of some contraceptive methods
currently in use for fertility regulation:
Steroidal contraception (oral or long acting)
Intrauterine devices (lUD's)
Barrier methods (condoms, diaphragms etc.)
Spermicidal products
Vasectomy and female sterilization
To a large extent, the methods of birth control avail
able at this time still do not satisfy all of the varied
cultural and service demands of different populations.
There is an expressed need to develop a greater variety of
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methods which would find wide acceptance, particularly in
developing countries.
At present, vaccines are the greatest practical benefit
that immunology has given humanity.

After all these years,

what is still essentially Jenner's vaccine against smallpox
appears to have eliminated the disease worldwide.

To date,

most vaccines for human and animal health have been composed
of whole organisms, viruses, or bacteria capable of inducing
high levels of immunity over long periods of time.

A birth

control vaccine eliciting a specific, safe, low-cost, and
effective antifertility immune response lasting for 1-2
years would have a major impact in family planning programs.
The basis for a vaccine lies in the induction of a
specific immune response to gamete or pre-embryo antigens.
In order to be effective, an antifertility vaccine requires
that the antigen be unique to the reproductive tract and
that the antigen have a fertility-related function.

Thus,

the antigen must be absent from other tissues, and it must
have an action that can be blocked by an antibody or be
located on a cell that can be lysed by complement.

Efficacy

and reversibility are two important criteria for an immunocontraceptive vaccine.

To be used for fertility regulation,

a vaccine antigen must be expressed on the sperm surface
(either an integral membrane protein or epididymal or
seminal plasma-derived coating protein) and be accessible to
immune attack.

It must be immunogenic so that either alone
2
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or in concert with conjugated proteins or adjuvant, a sus
tained and effective immunologic contraceptive response can
be elicited.

Furthermore, the antigen must be sperm

specific so that no tissue damage occurs from cross-reaction
(Anderson and Alexander 1983).
The possibility of inducing antibodies against repro
ductive tract antigens by deliberate immunization was sug
gested as early as 1899 by the pioneering work of
Landsteiner (1899) and Metchinikoff (1899) , and immunocontraception research has in recent years taken on new
importance and such a great increase in activity.

Experi

mental immunocontraception approaches are directed at inac
tivation of either one or more hormones, gametes, or pre
embryo antigens.
The development of an effective contraceptive vaccine
appears attractive in the male.

Currently three possible

immunogens are being considered.

Two (gonadotropin-releas

ing hormone and follicle stimulating hormone) are polypep
tide hormones and the third (lactic dehydrogenase-C4) is a
sperm-specific protein.

Although sperm-specific antigens

have been shown to be effective immunogens (Goldberg et al.
1986) , their contraceptive efficacy has only been demon
strated by immunizing females, and, as such, they do not
qualify as a vaccine for the male.
A number of other immunogenic sperm specific antigens
[acrosin, hyaluronidase, and rabbit sperm autoantigens
3
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(RSA-1)] have been identified and characterized.
approach would involve immunization of females.

Such an
The feasi

bility of this approach is based on two lines of evidence.
The first line of evidence comes from numerous studies of
human involuntary infertility which demonstrated that anti
sperm antibody-mediated immunoinfertility reduces fertility
in men and women (Menge, 1980).

The second line of evidence

comes from immunization studies of male and female animals
of various species with sperm specific antigens.

Immuniza

tion with extracts of sperm or mature testis has been shown
to result in a significant reduction of fertility, embryo
failure, or pre-implantation embryo mortality (Edwards,
1964; Menge, 1970; Kiddy and Rollings, 1973).

Immunological Aspects of Contraception By Immunization
Infertility can be induced in experimental animals when
they have been immunized against spermatozoa, seminal plas
ma, testicular, oocyte, and trophoblast antigens. Theoreti
cally, immunological factors would operate at any stage in
the reproductive process (Fig. 1) since the gametes and the
fertilized eggs, as well the hormones, tissues and other
secretions in their environment, are all potentially anti
genic and capable of eliciting an immune response.

Fertili

ty can be impaired in mammals by employing active or passive
immunization against testis antigens, spermatozoa or seminal
plasma in females (Mancini 1971; Tung 1980).

The resulting

4
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FIG. 1

Some Immunological Antifertility Effector
Mechanisms in the Male and Female
Reproductive Systems

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout p erm ission .

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Bladder
Inhibition of Capacitation
or Acrosome Reaction
Block Sperm/Egg recognition,
Binding or Fusion

vesicxe

Inhibition of Sperm Motility,
(e.g., SA/SI)

Ovary
Cervix

Prostate

Embryo loss

Vagina
Inhibition of Spermatogenesis
in the testis

U1

Epididymis

Inhibition of Sperm Maturation
in the epididymis
J

Female Reproductive System

Testis

Male Reproductive System

antibodies seem to prevent spermatozoa from achieving fer
tilization.

Similar studies have also been carried out on

males in attempts to destroy the seminiferous epithelium or
to suppress the fertilizing ability of the spermatozoa in
the male reproductive tract (for review see Shulman, 1971).
Spermatozoa, although immunologically foreign to women,
usually do not stimulate humoral immune responses with
coitus.

Deliberate immunization of females with sperm can

impair their fertility due to a combination of antisperm
antibody effects.

Intrinsic sperm antigens are produced

during germ cell maturation in the testis (O'Rand et al.,
1981) or epididymis.

Sperm coating antigens are added

during sperm passage through the epididymis (Blaquier et
al., 1986) and upon exposure to seminal plasma at ejacula
tion.

Antibodies to these intrinsic antigens and coating

antigens are associated with unexplained infertility
(Isojima et al., 1968).

Clinical syndromes have been iden

tified where male and female infertility almost certainly
has arisen due to antibodies against spermatozoa (Ansbacher,
1973; Alexander, 1983).

Serum and cervical mucus from the

female partner of infertile couples with poor postcoital
test reports were tested (Dondero et al., 1978) against
sperm from the normal male partner as well as sperm from a
donor to see whether the infertility arises due to antibod
ies against spermatozoa.

Also vasovasostomized men fre

quently have had antisperm antibodies in their seminal
6
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plasma. Antisperm antibodies identified on the male part
ner's sperm using both the immunobead assay and the radiolabeled antiglobulin assay have been associated with an
inhibition of cervical mucus penetration (Fuchs and
Alexander, 1983).
Various cellular responses and immunoglobulin classes or
subclasses could be involved in the reactions leading to
infertility.

Investigations of infertile women have re

vealed the presence of plasma IgG and IgM reactive with
spermatozoa (Bronson, 1990).

Antisperm antibodies of the

IgM, IgG, and IgA classes may agglutinate sperm so that
these sperm are unavailable to complete any further repro
ductive functions (Franklin and Dukes, 1964).

For example,

this agglutination may prevent normal progress through the
cervical mucus during transit in the female reproductive
tract.
Immunity to sperm can compromise fertility by:

(1) a

reduction in the number or quality of maturing sperm cells
(Mancini et al., 1965); (2) interference with sperm motility
(Mathur et al., 1984, 1986); (3) capacitation or the acro
some reaction (Saling, 1986); (4) decreased penetration of
cervical mucus (Fjallbrant, 1969; Kremer and Jager, 1976);
(5) enhanced phagocytic clearing of sperm from the female
genital tract (Muscato et al., 1982); (6) sperm cytotoxicity
given adequate levels of complement (Mathur, 1988);
(7) inhibition of sperm enzyme (Dunbar, 1976);
7
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(8) impairment of sperm-egg interaction (Saling et al.,
1985); (9) embryonic loss (Menge et al., 1982; Jones, 1976).
Since many of the vital events of sperm/egg interaction
are associated with the sperm membrane, it is likely that
antibodies to the membrane antigens may make ideal candi
dates for immunocontraceptives.

Sperm Antigens

The sperm plasma membrane is a mosaic of antigenic
domains.

Many of them are only produced in male reproduc

tive tract.

Antibodies produced to these antigens may be

responsible for reducing fertility in immunized animals.
Normal fertile ejaculates contain spermatozoa and a fluid
called seminal plasma.

Upon ejaculation, the sperm surface

is coated with the seminal plasma components, some of which
are so tightly bound that they cannot be readily eluted by
simple washing with physiological saline or organic solvents
(Scacciati and Mancini, 1975).
Human spermatozoa can be divided into three parts:
head, neck, and tail.

The sperm head is composed of the

nucleus and the surrounding membrane structures (Fig. 2).
The nucleus contains a haploid number of chromosomes and
nucleoproteins, and it often has small, irregular shaped of
clear areas referred to as nuclear vacuoles.

The membrane

structure of the sperm head consists of four parts:

(1) the

plasma membrane that covers the entire surface of the sperm
8
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FIG. 2

Schematic Diagram of Human Spermatozoa
a. Normal spermatozoa showing 7 different
regions
b. Cross section of human sperm head
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head; (2) the acrosome, a bag-like structure that surrounds
the anterior portion of the nucleus; (3) the post nuclear
cap, a cytoplasmic sheath that covers the posterior part of
the nucleus; and (4) the equatorial segment.
Antigens of human sperm have been mapped and many re
searchers report that naturally occurring human antisperm
antibodies bind to antigens located on the acrosome, post
acrosome, equatorial region, midpiece, and tail.

Three

types of semen specific antigens have been defined;
(1) antigens in seminal plasma; (2) sperm coating antigens
(adsorbed epididymal and seminal plasma components on the
surface of spermatozoa); and (3) genuine or intrinsic spermatozoal antigens.

The various groups of intrinsic sperma-

tozoal auto- and iso-antigens are listed (Hjrot et al.,
1982) in Appendix, Table A.
The most potent sites for interfering with the fertil
ization capacity of spermatozoa are likely to be on the
outer and inner acrosomal membrane.

Attachment of antibod

ies to such sites would be expected to interfere with sever
al crucial aspects of sperm function which include the
vesiculation of the plasma membrane and subsequent release
of soluble enzymes, as well as the binding of spermatozoa to
receptor sites on the zona pellucida and oolemma.
Specific cell-cell contacts that occur during mammalian
fertilization are probably initiated through non-covalent
protein-protein and protein-carbohydrate interactions
10

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout p erm ission .

between surface membrane components (Fig. 3).

Any compre

hensive understanding of fertilization therefore requires a
definition of these surface components and their chemical
nature, localization on the cell surface and expression
during gamete maturation and fertilization.

The Development And Changes Of Sperm Membrane Antigens
During Spermatogenesis And Epididymal Maturation
Human spermatogenesis occurs in the seminiferous
tubules at an average age of 13 years as the result of
stimulation by anterior pituitary gonadotropic hormones.
Figure 4 illustrates the various portions of the male repro
ductive system associated with spermatogenesis and sperm
maturation.

During spermatogenesis, dynamic cellular inter

actions take place.

These are governed partly by initial

recognition events involving plasma membranes of the cell
within the seminiferous tubules.

The expression of many

sperm surface macromolecules occurs at a precise time in
spermatogenesis.

1.

Testicular Spermatozoa
In all mammals, including man, testicular spermatozoa

are not capable of forward movement and are infertile.

They

are, however, similar in biochemical composition and struc
ture to spermatozoa in other regions of the reproductive
tract.

Compared to ejaculated spermatozoa, testicular
11
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FIG. 3

Schematic Diagram of Sperm Plasma
Membrane Components
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FIG. 4

Schematic Diagram of Portions of the Male
Reproductive System Associated with
Spermatogenesis (TESTIS) and
Sperm Maturation (EPIDIDYMIS)
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spermatozoa contain more proteins, sodium, calcium, and have
a high rate of glucose oxidation and lactic acid production,
high levels of neutral lipids and phospholipids and low
levels of fatty acids and ATPase. Differences in the amount
and composition of lipids in the plasma membrane of testicu
lar spermatozoa may account for their higher charge density
at the phospholipid-water interface of these spermatozoa, as
well as for their higher membrane fluidity compared with
that of epididymal and ejaculated spermatozoa.
Studies in animals reveal that testis-specific auto
antigens appear on the late pachytene spermatocytes and
persist through spermatogenesis (Millette et al., 1977).
However, some antigens, which appear first on B spermatogo
nia, are found at all stages of spermatogenesis, on sperma
tids, and even on residual bodies, but not on mature sperm
(Romrell and O'Rand, 1978).

Additional antigens appear on

the plasma membrane after the midspermatid stage of sper
matogenesis (Romwell et al., 1978).

Phelps and Myles 1987

have reported that three monoclonal antibodies, PH20, PH21,
and PH22, bind to the PH20 protein of guinea pig sperm.
They all bind to the entire surface of testicular sperm, and
their binding sites are restricted to the posterior head of
the cauda epididymal sperm.

On the other hand, PH30 repre

sents an antibody that does not bind to testicular sperm
even though PH3 0 protein is present on testicular sperm.
this case the epitope recognized by the PH30 monoclonal
13
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In

antibody is not available on testicular sperm.

Binding of

this monoclonal antibody is first observed on cauda sperm
where the antigen is restricted to the posterior head region
(Primakoff et al., 1987).

Similar human germ cell- and

sperm-specific antigens, as revealed by mapping studies with
monoclonal antibodies, develop during spermatogenesis
(Anderson et al., 1987) and on the sperm surface during
epididymal transit (Feuchter etal., 1981).

The testicular

sperm surface membrane is characterized by the presence of
major species-specific high-molecular-weight proteins (105115KD in the boar, Dacheux et al., 1989; 95-119KD in the
ram, Dacheux and Voglmayr, 1983; 110-130KD in the rat, Jones
et al., 1981; 110KD in man, Dacheux et al., 1987).

Most of

these testicular surface proteins gradually disappear in the
first part of the epididymis.

Some other compounds are

removed very soon, such as 75-97KD compounds in the boar
(Dacheux et al., 1989) and 78-88KD compounds in the ram
(Dacheux and Voglmayr, 1983).

2.

Epididymal Spermatozoa
The testicular spermatozoa and fluids pass to the

caput region of the epididymis, then through the corpus
portion into the cauda portion.

Transport of the spermato

zoa from the corpus to the cauda requires from one to three
weeks. Spermatozoa, as they transit the epididymis, mature
and gain fertilizing ability (Asch and DeCherney, 1987) .
14
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Sperm undergo changes in surface charge, surface carbohy
drate composition, intramembranous particle distribution,
plasma membrane fluidity, plasma membrane lipid composition,
and surface protein and glycoprotein makeup during epididy
mal maturation (Eddy et al., 1985; 1988).

Changes in sur

face charge can be observed by an increased binding of
cationic colloidal iron particles, cationic ferritin, and
positively charged beads (Olson and Danzo 1981).

Spin

resonance studies have detected a decreased charge density
at the phospholipid-water interface.

These changes in net

surface charge probably result from a variety of additions,
modifications and deletions of sperm surface moieties during
epididymal maturation (Rodriguez-Rigau et al., 1982).
Changes in sperm surface carbohydrate composition
have been observed during maturation and include decreases
in the total bound sialic acid, and increases and decreases
in the binding of various lectins to the sperm surface.
These changes appear to result from the addition and removal
of saccharide moieties (Eddy 1988) . For example, galactosyltransferase activity is present on the surface of the
sperm and in epididymal fluid.

This enzyme is required for

mouse sperm binding to zona pellucida (Lopez et al., 1985).
Major changes in sperm surface protein and glycopro
tein composition occur during maturation through (1) the
addition of new components, (2) the unmasking or modifica
tion of preexisting moieties, or (3) the loss of surface
15
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components.

Changes in individual surface proteins or

glycoproteins often occur within discrete regions of the
epididymis, probably as the result of regionally specialized
activities of the epididymal epithelium.

The disappearance

of sperm surface proteins is sometimes associated with the
appearance of new proteins.

Among the new membrane surface

compounds of the sperm appearing during epididymal transit,
most are characterized by a low molecular weight (range, 1436K). Such events have been described in the.rat (Brown et
al., 1983; Brooks and Tiver, 1984), the ram (Voglmayr et
al., 1982, 1985), the hamster (Moore and Hartman, 1986), the
chimpanzee (Gould et al., 1984), and the human (Dacheux et
al., 1987) sperm.
During maturation, the sperm plasma membrane under
goes changes in lipid content.

There is a decrease in

cholesterol, and there are significant decreases and in
creases in a variety of plasma membrane lipids, but there
are no significant changes in the cholesterol/phospholipid
ratio (Nikoloupoulou et al., 1985).

However, changes, in

amount and composition may not occur uniformly in all re
gions of the sperm plasma membrane during maturation.
Freeze-fracture studies have demonstrated changes of intramembranous particles within the plasma membrane during
maturation, specifically in the acrosomal and post acrosomal
region (Friend and Fawcett 1974).

Expression of this matu

ration phenomenon are manifested in the changes in antigenic
16
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properties of spermatozoa during epididymal transit as a
result of the addition, substraction and modification of
antigens on the cell surface (Tezon et al., 1985b; Eddy et
al., 1988). Substantial progress in this area was achieved
in recent years with the demonstration that androgen-induced
glycoproteins secreted by the epididymis became associated
with the surface of spermatozoa during maturation (Tezon et
al. 1985a), Synchronous with this interaction, the cells
developed the fertilizing ability which characterizes mature
sperm.

Major advances in characterizing the changes that

occur at the sperm surface during epididymal maturation have
come from the use of immunological tools to study this
process.

These approaches have been useful for demonstrat

ing quantitative changes in the sperm surface during epidid
ymal transit, for identifying new surface components that
arise during epididymal maturation, and for determining
where such components originate in the epididymis.

Support

ing evidence of a biological role of epididymal glycopro
teins in maturation was obtained by using the alternative
approach of blocking the biological activity of these anti
gens with specific antibodies (Fournier et al. 1985).
Tezon et al. (1985) have shown that the antigens
secreted by the proximal segments of the epididymis tend to
accumulate in the epididymal plasma and on the spermatozoal
surface as they pass through the organ.

This finding sug

gests a gradual incorporation of antigens from the
17
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surrounding milieu into the cells.

Based on this observa

tion, they extracted these antigens from the surface of
ejaculated spermatozoa.

A fraction corresponding to the

proteins of epididymal origin was used to raise a polyclonal
antiserum in rabbits.

When incubated with sperm, the anti

serum localized the antigens mainly on the acrosomal cap
region of the ejaculated spermatozoon with minor localiza
tion on the midpiece and flagellum.

These researchers also

showed that these epididymal antigens have a role on spermoocyte interaction.

Blanquier et al. (1986) also suggested

a significant relationship between infertility and defective
antigen content or localization.

The Prefertilization Stages of Spermatozoa During Transit
Through Female Reproductive System
The interaction and fusion of male and female gametes
in the fertilization process is a multistep phenomenon that
is still not well understood at the molecular and biochemi
cal level.

Immediately following coitus in primates and

ruminants, spermatozoa encounter the cervical mucus, a fluid
with complex physical properties.

The physical properties

of mucus contribute to several important cervical functions
in these species, including exclusion of seminal plasma, the
selective exclusion of certain sperm cells with morphologi
cal and, possibly, functional abnormalities; and the

18
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retention and conservation of sperm for later migration to
the upper tract.
During transit in the female reproductive tract,
spermatozoa undergo physiological and biochemical changes
during a process called capacitation.

This process involves

loss of sperm-surface molecules, including lectin and anti
body-binding sites (Koehler, 1978; Schwarz and Koehler,
1979).

Capacitation prepares the spermatozoa to undergo the

acrosome reaction and the hyperactivated motility that may
enhance the ability to penetrate the zona pellucida. Capaci
tation has been described as a reversible process involving
shifting and shedding of surface components of the plasma
membrane acquired during epididymal transit and at ejacula
tion (Weinman & Williams, 1964).

During capacitation, there

is a decrease in membrane cholesterol and a change in the
phospholipid composition in the plasma membrane, thus alter
ing the cholesterol/phospholipid ratio (Langlias & Roberts,
1985).

These alterations modulate membrane fluidity.

The

net negative charge of the membrane is reduced due to the
removal of sialic acid residues (Farooqui, 1983) and sulfate
residues (Langla et al., 1981) by hydrolases present in the
female reproductive tract.

Antisperm antibody H316 appears

to bind to the human sperm acrosome only after capacitation
and may be useful as a probe identifying capacitated sperm
(Anderson et al., 1986).

Antibodies directed against the

plasma membrane of sperm can affect the mobility of membrane
19
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particles; thus impeding or possibly hastening capacitation.
Support of this hypothesis comes from the finding that some
antisperm antibodies exposed to sperm prior to capacitation
prevent sperm fusion with hamster eggs (Alexander, 1984).
One end point of capacitation may be the hyper
activation of sperm.

This vigorous pattern of movement

observed in capacitated sperm was first reported in the
hamster in 1970 (Yanagimachi, 1970).

Later it was reported

in other species, including man (Burkman, 1984).

These

movements may enable sperm to overcome the physical resis
tance of the vestments which surround the oocyte.

When

sperm antibodies directed against the plasma membrane affect
sperm capacitation, they may inhibit sperm hyperactivation
too.

If sperm do not become hyperactivated, no penetration

of zona pellucida or fertilization can occur (Fraser, 1981).
The end point of capacitation is the acrosome reac
tion, an exocytotic event made up of a series of steps.

The

anterior region of the head swells and the outer acrosomal
membrane fuses with the plasma membrane.

The release of

most of the acrosomal contents occurs next.

Finally there

is a loss of the shroud of the fenestrated membrane so that
the inner acrosomal membrane becomes the external face of
the sperm.

Although it is still debatable whether the zona

pellucida initiates the acrosome reaction, this oocyte
vestment does provide the primary sperm contact during
fertilization (Wassarman, 1988).

Antisperm antibodies may
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mask the sites of induction of the acrosome reaction or
reduce membrane mobility, and thus prevent its occurrence.
Saling et al. (1986) reported that a monoclonal antibody
directed against a sperm antigen prevents zona penetration
by inhibition of the acrosome reaction.
During penetration, the spermatozoa must pass through
the outer oocyte layers and arrive at the vitelline membrane
in a state that is appropriate for fusion with this mem
brane.

A mature ovulated egg (Fig. 5) has three layers of

outer vestments through which the spermatozoa must pass:
(1) the cluster of surrounding follicle cells, the cumulus
oophorus, (2) the dense cellular layer present between the
cumulus and the zona, the corona radiata, (3) the noncellular coating known as zona pellucida.
of zona is glycoprotein.

The major constituent

Antibodies can also impede sperm-

egg fusion (Saling et al., 1985).

Antibody directed against

the zona can prevent sperm binding (Henderson et al., 1987;
Sacco, 1987).

In the rabbit and guinea pig, antisera to

sperm membrane antigens interfere with zona binding and
penetration (Primakoff et al., 1988; O'Rand, 1981). Anti
sperm antibody in patient sera may also interfere with zona
interaction ( Bronson et al., 1982; Tsuku, 1986; Mahony et
al., 1991).

Several studies have demonstrated that anti

sperm antibodies can reduce hamster-egg penetration by human
sperm (Alexander, 1984; Haas et al., 1980).

Sperm penetra

tion through the zona pellucida requires an initial period
21
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FIG. 5

A Mature Ovulated Human Egg With 3 Vestments
Through Which The Spermatozoa Must Pass
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of time during which the spermatozoa attach and bind to the
zona surface.

This binding of spermatozoa to the zona is a

tight, species-specific interaction and suggests that the
zona pellucida may have sperm receptors on its surface.

The

putative presence of sperm receptors on the zona pellucida
makes it likely that there are complementary egg-binding
proteins.

The murine zona pellucida is composed of three

sulfated glycoproteins designated ZP1, ZP2, ZP3 (Bleil and
Wassarman, 1980).

ZP3, with a molecular weight of 83,000

daltons, has been proposed as a species specific sperm
receptor.

Antibodies directed against these receptor sites

could interfere with zona attachment and subsequent penetra
tion.

Recently researchers from our institute (Coddington

et al., 1991) evaluated some monoclonal sperm antibodies to
see if any antisperm antibodies could impede sperm-zona
binding.

Two monoclonals significantly decreased zona

binding after exposure to MA-14 and MA-27.

Another study

from our laboratory (Mahony et al., 1991) evaluated 26
antisperm monoclonal antibodies from a WHO (World Health
Organization) panel with the hemizona assay.

Among these,

six monoclonals (S04, S19, S34, S58, S61, and S65) showed
inhibition of zona binding (HZ index <50).
about the mechanism of the binding process,

Little is known
it may bind to

an intact plasma membrane, or a vesiculated surface, or an
inner acrosomal membrane, or through a combined sequential
reaction involving all three.
23
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Monoclonal Antibodies and Their Significance to Studies of
Immunoreproduction
Antibodies produced from a cell line that has arisen
from the growth and division of a single cell to form a
clone are called monoclonal.

Ever since the beginning of

the experimental immunology at the end of nineteenth centu
ry, scientists have explpited the specificity of antibodies
to detect, isolate, and analyze biological material.

The

power of antibodies as probes for biological structure
underwent a quantum increase in 1975, when Kohler and
Milstein discovered a method for generating monoclonal
antibodies.

A number of hybridomas producing antibodies

reactive against sperm have been developed.

Monoclonal

antibodies (MAbs) have proven to be highly useful probes for
studying sperm surface components and for dissecting the
structure and function of the male gamete.

They have been

used to map the domains of the sperm surface, to determine
the time of appeairance of future sperm surface components
during spermatogenesis, to examine the species specificity
of antigenic determinants on the sperm surface, and to
follow the fate of sperm components after fertilization
(Eddy, 1988).

MAbs have also been used to detect auto

antigens and to test the role of surface components in the
binding of the sperm to the zona pellucida and in fertiliza
tion (O'Rand, 1981; Saling, 1986).

Because these monoclonal

antibodies permit the study of single sperm antigens,
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researchers have produced monoclonal antibodies that recog
nize components of sperm from a variety of species including
man (Lee et al., 1982; Isahakia and Alexander, 1984? Naz et
al., 1984? Wolf et al., 1983).

Human sperm antigens are

being studied through application of sperm specific mono
clonal antibodies and evaluation of their biochemical and
functional characterization.

These antibodies will provide

insight into the mechanisms of immunological infertility as
well as contributing to the development of contraceptive
vaccines.

The WHO Monoclonal Antibody Workshop identified a

number of antisperm monoclonal antibodies that recognized
functionally significant sperm antigens (Anderson et al.,
1987).

The production of monoclonal antibodies directed

against sperm provides a powerful tool for definition of new
antigens that may be involved in fertilization.
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CHAPTER 2

LITERATURE REVIEW

Ever since Landsteiner (1899) discovered the antigenic
properties of human spermatozoa, various investigators have
studied the phenomenon of immunologic infertility.

Early

attempts have been made to induce infertility in females by
immunization with whole spermatozoa and with seminal plasma.
In the last ten years, research has centered on using
various antigens in purified forms to induce infertility in
mice (Edwards, 1964), guinea pigs (D'Almeida and Voisin,
1979; Primakoff et al., 1988), rabbits (Munoz and Metz,
1978), and primates (Goldberg, 1981).

To be used for fer

tility regulation, a vaccine antigen must be expressed on
the sperm surface (either an integral or coating protein).
It is therefore logical to develop antisperm antibodies to
sperm surface antigens.

Definition of mammalian sperm

surface domains at the molecular level has been achieved
using lectins as probes (Schwartz et al., 1979), covalent
protein labels such as [ 125l ]-diiodofluorescein isothiocyanate (Herr and Eddy, 1980), polyclonal antibodies raised
against sperm antigens (Herr and Eddy, 1980), and monoclonal
antisperm antibodies (Myles, 1981; Schmell, 1982; Wolf,
1983) . Additionally, discrete patterns of intramembranous
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particle distribution in the plasma membrane have been
defined by freeze-fracture replica techniques (Friend et
al., 1977; Yanagamachi, 1990).

At present, however, rela

tively little is known about the association of such re
stricted domains to cellular function. Characterization of
the human sperm surface is in its infancy.
Studies of membrane antigens have been facilitated
greatly by the availability of monoclonal antibodies to
individual determinants of antigens in complex mixtures.
Clones of antibody-producing cells can provide banks of
antibodies for use in typing cells according to the antigens
present on their surfaces, and sufficient quantities of
antibodies can be produced readily to support antigen isola
tion.

The method for generating monoclonal antibodies has

been used to develop a number of hybridomas producing anti
bodies reactive against sperm from mouse (Saling, 1985a,
1985b), rabbit (O'Rand et al., 1984) and guinea pig
(Primakoff et al., 1988).

Monoclonal antisperm antibodies

are being used to study antigen expression during develop
ment and differentiation in spermatogenesis and epididymal
maturation in the mouse (Bechtol, 1979).

A

WHO-sponsored

workshop, mentioned in the last chapter, was held to review
the current status of monoclonal antibodies regarding their
effects on molecular events underlying reproduction and the
feasibility of using this approach to identify trophoblast
and sperm specific antigens that might represent suitable
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candidates for contraceptive vaccine development.

A list of

66 mouse monoclonal antibodies reacting with human sperm
submitted by 29 labpratories is shown in Appendix A
(Anderson et al., 1987).

The immunizing antigen in most

cases was washed human ejaculated sperm or human sperm
antigen extract; exceptions included S23-29 (purified mouse
LDH-C4), S22 (baboon epididymal sperm), S12 and S57 (synge
neic mouse sperm), S49 (rabbit sperm) and S60 (human chori
onic villous surface membrane). S51 and S50 were two con
trols reactive against sheep red blood cells respectively,
and NS.l is a Ig-deficient ascites fluid produced by an
unfused murine myeloma cell line.

These antibodies were

evaluated in coded form by 42 laboratories with the appro
priate expertise in biochemistry, immunohistology and the
testing of reproductive cell function.

The majority of

antisperm monoclonal antibodies cross-reacted with cellular
elements in non-reproductive tissues.

However, three anti

sperm MAbs appeared to demonstrate sufficient specificity to
warrant further investigation as reagents for the identifi
cation of antifertility vaccine candidates.

These three

sperm monoclonal antibodies, S20, S37, and S61, were identi
fied as primary vaccine candidates based on three criteria:
(1) reactivity with human testicular germ cells and to the
abundant surface antigens on mature spermatozoa; (2) minimal
cross reactivity with somatic cells; and (3) inhibition of
at least one sperm function assay (Lee et al., 1984; Moore
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et al., 1985? Herr et al., 1986).

Although a panel of these

monoclonal antibodies has been made from several animal spe
cies, (Feutcher et al., 1981; Schmell et al., 1982? Isahakia
and Alexander, 1984) only a few have been examined as to
their effects on fertilization (Naz et al., 1984a; 1984b).
Numerous human testicular germ cells and placental cDNA
libraries are now available and provide a resource for
cloning these vaccine candidates.

To probe the library,

monoclonal antibodies that can specifically affect fertil
ization without cross-reacting with normal somatic cells are
required.

The Characterization of Sperm Surface Antibodies
A.

Sperm Functional Analysis
Two tests are commonly used to detect free antisperm

antibodies, the sperm agglutination test (Kibrick et al.,
1952) and the sperm immobilization test (Isojima et al.,
1968) . Sperm-agglutinating antibodies are most commonly
found in vasectomized men (65%) ; sperm-immobilizing antibod
ies are found in 40% of vasectomized men (Ansbacher, 1971).
Agglutinating antibodies are found in less than 10% of the
infertile women, whereas sperm-immobilizing antibodies are
found in about 8%. This agglutination and immobilization may
prevent normal progress through the cervical mucus during
transit in the female reproductive tract.

Complement depen

dent immobilization may result in damage to both the
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acrosome membrane and the entire plasma membrane
(LeBouteiller, 1975).

Antisperm antibodies of the IgM and

IgG classes may agglutinate sperm (Ingerslev et al., 1979)
but only IgM and some subclasses of the isotype IgG are able
to immobilize sperm by initiating the classical complement
cascade (Brown et al., 1984).

Antibodies of isotype IgA do

not fix complement so they cannot immobilize sperm.
Recently an immunobead test involving micrometer-sized
polyacrylamide beads coated with covalently bound anti
immunoglobulin antibody was developed for the detection of
antisperm antibodies to sperm surface membrane antigens
(Bronson et al., 1984).

This assay can provide information

on the location of the antibodies on the sperm surface (for
example, on the head, tail, midpiece or tail-tip) and immu
noglobulin class

G, M or A (Bronson et al., 1981; 1982).

Many monoclonal antisperm antibodies exhibit actions and
specificities similar to those of naturally occurring anti
sperm antibodies in human beings; for example, one has been
reported that causes complement-dependent immobilization but
not agglutination of human sperm
1984).

(Isahakia & Alexander,

A monoclonal antisperm antibody may cause neither

sperm agglutination nor sperm immobilization but prevent
gamete interaction.

There are some in vitro and in vivo

tests which can be used to detect any inhibition of sperm
egg interaction due to antisperm antibodies.

The first

interaction of the spermatozoon and egg involves tight
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binding of spermatozoa to the zona pellucida.

This highly

species specific binding involves complementary sites on the
receptors of the surface of the gametes (Ahuja, 1985)•

The

irreversible binding of sperm and zona necessary for fertil
ization and some types of male infertility have been
demonstrated to be due to failure of spermatozoa to complete
this adhesion (Overstreet et al., 1980).

Overstreet et al.

(1976) first suggested the use of zona intact non-living
oocytes to examine the sperm-zona pellucida binding.
Burkman et al. (1988) at our Institute have further modified
this hemizona assay (HZA) technique.

The HZA is being used

as a clinical tool to evaluate patients and is predictive
for fertilization potential (Franken et al., 1989b).

The

hemizona assay can be used to evaluate whether antisperm
antibodies impede binding.

When sperm were coincubated with

antibody for one hour, some monoclonal antisperm antibodies
markedly inhibited binding, thus providing evidence that
such antibodies could potentially reduce fertility (Mahony
et al., 1991).
The zona-free hamster penetration test (SPA) has been
used extensively in many laboratories to examine the role of
antisperm antibodies in fertilization.

Our laboratory

(Alexander et al., 1983) and others (Haas et al., 1980; Dor
et al., 1981) have observed that antisperm antibodies, espe
cially of the IgG isotype, interfere with human sperm pene
tration of hamster egg membrane.

When sera from patients
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with immunologically-mediated infertility were exposed to
normal sperm, the ability of their sperm to penetrate ham
ster eggs was much reduced or eliminated.

A penetration

rate of 59% was observed for the control sera as compared to
only 15% for the test sera.

Fully 90% of the sera from

patients with antibodies to sperm caused a reduction in egg
penetration rates.
Antisperm antibodies can significantly inhibit in vitro
fertilization of mouse eggs by murine sperm (Naz et al.,
1984a). In vivo (by passive immunization) fertilization can
be used (Naz et al., 1984a; Saling and Waibel, 1985) on
animal models for primary evaluation of fertility effects
due to antisperm antibodies.

Immunization with an anti-

idiotypic antibody which mimics sperm antigen structure
could be completed (Carron et al., 1988).

The mouse mono

clonal antisperm antibodies M42.14 and M29.6 recognized
distinct mouse sperm antigens which prevented mouse fertil
ization in vitro and in vivo (Saling, 1986).

There are

several advantages associated with the application of human
antibodies for passive immunization using animal models to
test their effect on fertilization:

(1) They are a cheap

source of unlimited amount of well characterized and sero
logically very specific reagents; (2) The degree of immuni
zation is directly proportional to the amount of the anti
body applied, and does not depend on individual variation
response; (3) The action is shortlived and is. fully
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reversible; (4) As they are human proteins, severe immuniza
tion against other cells do not seem to be probable even if
they are applied several times sequentially.

B. Biochemical Characterization
Western blot techniques have revealed that, even
though an antibody reacts to what appears to be the entire
acrosome, antigens of differing molecular weights may be
involved.

Primakoff and Myles (1983) have found guinea pig

sperm head antigens ranging from 18 to 70 Kd, and our labo
ratory has observed human sperm acrosomal antigens varying
from 34 to 240 Kd.

In elegant studies, Reynolds and

Oliphant (1984) have used monoclonal antibodies to charac
terize an acrosome-stabilizing factor, a 360 Kd dimer syn
thesized in the corpus epididymides and found in seminal
plasma and caudal epididymal fluid.

This substance main

tains the acrosome during epididymal storage and prevents
the acrosome reaction.
As was mentioned, during the fertilization process,
the sperm cell must successfully interact with two primary
surface constituents of the egg, the zona pellucida (an
extracellular glycoprotein.layer that surrounds the egg) and
the egg plasma membrane.

Sperm-zona interaction involves

the binding of the sperm to species-specific receptor mole
cules present within the zona (O'Rand, 1988).

A number of

studies have indicated that carbohydrate moieties present
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within the zona pellucida or on the surface regulate this
interaction. Competitive inhibition studies using various
monosaccharides, polysaccharides or glycoproteins have
indicated a role for specific carbohydrate moieties in
mediating sperm-zona interaction in hamsters (Ahuja, 1982)
and mice (Wasserman and Bleil, 1982).

Treatment of either

the zona pellucida or sperm with glycosidic enzymes also
inhibits sperm binding to the zona in a variety of species
(Ahuja and Gilbert, 1985; Shur and Hall, 1982).

The possi

bility that sperm-egg fusion involves carbohydrate compo
nents of the sperm and/or egg

plasma membrane is suggested

by observations in other membrane fusion systems where
glycoproteins play a critical role in the fusion process.
Once these antigens have been elucidated, they can be used
both in infertility assessment and production of a contra
ceptive vaccine.
Lectins, such as concanavalin A and wheat germ agglu
tinin, are plant proteins that have multiple binding sites
for specific sugars.

Wheat germ agglutinin, for example,

binds to glucose and mannose.

Most plasma membrane glyco

proteins have multiple exposed sugar groups; thus, lectins
cross-link glycoproteins that have multiple appropriate
sugar substituents.

Monoclonal antibodies against sperm

membrane glycoproteins often react with antigenic determi
nants common to more than one cell-type, and such
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cross-reactivity is mainly due to glycoconjugates on the
cell surface (Anderson et al., 1987).
Production and characterization of antisperm monoclonal
antibodies will aid in understanding fertilization and be a
step toward contraceptive vaccine development.
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CHAPTER 3

SPECIFIC AIMS

Specific aims of this project are to

1.

Develop murine monoclonal antibodies directed against
human sperm surface antigens.
a.

Prepare sperm membrane (both coating and integral)
antigen extraction from human ejaculated sperm and
from human testicular sperm.

b. Immunize Balb/c mice
i.

by conventional immunization technique and

ii.

by first tolerizing mice with common antigenic
sugar moieties to human sperm and somatic cells
and then immunize mice with human sperm
extracted antigens.

c. Perform the classical hybridoma technique to
generate Mabs against extracted sperm surface
antigens.
d.

Determine the class (isotype) and quantitate
antibodies.

2.

Localize antigens reacting with a particular MAb
restricted to the sperm surface on human by
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immunofluorescence (IF) and immunochemical stain
ing (ICS) .

3. Determine the molecular weight of antigens from
extracted sperm antigens that are recognized by these
MAbs by the immunoprecipitation technique and SDS-PAGE
(sodium-dodecyl sulfate polyacrylamide electrophoresis)

4. Determine the reactivity of MAbs with fresh, capacitat
ed, and acrosome reacted human sperm by enzyme linked
immunosorbant assay (ELISA) and ICS.

5. Determine whether these MAbs are against human sperm
surface antigens by the live sperm ELISA and the immuno
bead test (IBT).

6. Perform cross-reactivity studies evaluating generated
panel of MAbs using ELISA /or CB-RIA (cell-binding
radioimmunoassay) to sperm and other cell types (human
lymphocytes, erythrocytes) or do IF and ICS against a
panel of human tissues.

7. Localize the origination of sperm antigens in the repro
ductive system reacting with a particular MAb by IF and
ICS on frozen human reproductive tissue section.
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8.

Determine the cross reactivity of MAbs with other
species spermatozoa by IF and ICS.

9.

Determine whether these antisperm antibodies have
functional significance.

10.

a.

Sperm agglutination assay (SA)

b.

Sperm immobilization assay (SI)

c.

Cervical mucus penetration assay (CM)

d.

Hamster egg penetration assay (SPA)

e.

Hemizona assay (HZA)

Determine whether a carbohydrate moiety is involved on
the sperm surface antigen activity by means of inhibi
tion of carbohydrate moiety by sodium metaperiodate.

11.

Use passive immunization of any particular promising
antibody that also cross-reacts with mouse sperm to
determine whether a reduction in fertility occurs.
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CHAPTER 4

PURPOSE & SIGNIFICANCE

At present, no group of sperm antigens useful for
human immunocontraception has been defined.

The current

literature shows that the majority of extant monoclonal
antibodies cross-react with cellular elements in nonreproductive tissues.
For vaccine development, the reactivity to the abun
dant surface antigens on mature spermatozoa and the minimal
cross reaction with somatic cells are important criteria
(Anderson et al., 1987).

Therefore, the aim of our study is

to develop antisperm monoclonal antibodies to sperm membrane
surface antigens.
One approach is to use human sperm membrane prepara
tions.

This requires the definition of specific epitopes

that will not cross-react with other tissues but which
result in an

effective and reversible mode of contracep

tion.
Lectin binding studies of sperm membrane extracts
have identified abundant amounts of 4 sugar moieties (mannose, galactose, N-acetyl-glucosamine, and fucose) which are
common to many cell types (Kurpisz et al., 1989).

Thus, it

is not surprising that antisperm monoclonal antibodies often
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cross react with antigenic determinants common to more than
one cell type (Waibel et al., 1987; Anderson et al., 1987;
Tsuji et al., 1988).

In our proposed study we used a toler-

ization protocol to see if by tolerizing the mouse with
these common sugar moieties, we can prevent the cross
reactivity with other cells; hence, we can develop more
sperm specific monoclonal antibodies.

This approach may

also facilitate producing antibodies against surface pro
teins that are weakly immunogenic, even though these anti
gens may be involved in fertilization.
Seminal plasma-derived coating proteins and antigens
are expressed not only on sperm but may also be present on
somatic cells.

These antigens often appear to be more

immunogenic in the mouse than the gamete-specific compo
nents.

In order to eliminate the reactivity to seminal

plasma-derived coating protein, we also used an extract of
human mature testicular tissue to immunize mice.
Antisperm antibodies that inhibit zona binding are
also an area of interest in contraceptive research.

In

nonhuman models, antibodies to sperm antigens can inhibit
fertilization by preventing zona binding (O'Rand, 1981).
Whether the results obtained from animal studies can be
applied directly to the human system is not yet clear.

The

new hemizona assay has been used as a clinical tool to
evaluate patients and predict their fertilization potential.
Our laboratory has presented data (Mahony et al. 1991)
40

R ep ro d u ced with p erm ission of th e copyright ow ner. Further reproduction prohibited w ithout p erm ission .

showing that some antisperm monoclonal antibodies can inhib
it zona binding as determined by the hemizona assay,
although the antibodies may not inhibit any of the sperm
functional assays other than hamster egg penetration.

One

aim of this study is to screen our antisperm monoclonal
antibodies using this new hemizona assay.
The purpose of this study is to develop highly spe
cific antihuman sperm MAbs and to characterize some that are
functionally significant, so that in future study, these
could be used in a cocktail of significant antisperm mono
clonal antibodies to evaluate a cDNA library for production
of sperm antigens in vitro.

Definition and characterization

of these antibodies will aid in the understanding of sperm
function and fertilization and may provide a useful contra
ceptive approach.
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CHAPTER 5

EXPERIMENTAL DESIGN AND METHODS

SPECIFIC AIM NO. 1
Production of murine monoclonal antibodies directed against
human sperm surface antigens.

a.

Sperm surface (coating and integral) antigens extraction
from human ejaculated sperm and from human testicular
sperm

Extraction of human ejaculated sperm surface antigens
Researchers from our laboratory have recently
investigated and reported (Gupta et al., 1988) a method
of sperm antigen preparation to optimize production of
relevant monoclonal antibodies. Human semen ejaculates,
obtained from normal male donors or from men attending an
infertility clinic (The Jones Institute for Reproductive
Medicine, Norfolk), were allowed to liquefy at room tem
perature.

After liquefaction, 0.5 mL of semen was placed

beneath 2 mL Biggers, Whitten, Whittingham (BWW) medium
(Biggers et al., 1971) and motile sperm were allowed to
swim-up for a 90 min incubation period at 37°C.

Motile

sperm in BWW medium were pooled, counted with a Cell Soft
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Automated Semen Analyzer (Cryo Resources Ltd, NY), washed
three times in Tris-buffered saline (TBS) and stored at
-70°C, (swim-up sperm, Fig. 6).

A sperm pool was col

lected for protein extraction.
Sperm surface antigens were extracted from pools of
swim-up sperm as follows:

the volume of thawed sperm

(500 million sperm) was doubled by addition of 0.6% (0.3%
final conc.) of NP-40 in TBS (vol/vol), to which 1 mM
(final conc.) phenyl methyl sulfonyl fluoride (PMSF) was
added as a protease inhibitor.

The suspension was incu

bated for 1 hour at room temperature with continuous endto-end mixing. After extraction, the suspension was
centrifuged for 30 minutes at 20,000 g at 4°C.

The

supernatant was collected, pooled, and dialyzed exten
sively against TBS in a 3,500 molecular weight exclusion
dialysis membrane at 4°C.

Protein concentration was

measured by a BCA protein assay (Pierce Chemical Company)
according to manufacturer's suggested protocol insert.
Briefly, bicinchoninic acid, the key component in the BCA
protein assay reagent, formed alkali metal salts which
were soluble in water due to the polar carboxylic acid
groups.

The pyrole reaction product was measured spec-

trophotometrically at 562 nm.

A flow diagram of sperm

membrane antigen extraction procedure is shown in Fig. 7.
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FIG. 6

Improvement of Semen Parameters by Swim-up
(rise) Technique
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FIG. 7

A Flow Diagram of Sperm Membrane Antigen
Extraction Process
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Extraction of human testicular sperm antigen

The testicular sperm antigen preparation technique
developed by Liu et al. (1989) was followed.

Briefly, 10

grams of frozen human testes (obtained from National
Disease Research Interchange, Philadelphia, PA) was
homogenized in a glass homogenizer using 20 mL extraction
buffer containing 50 mM Tris-HCl, 1 mM phenylmethyl
sulfonylfluoride (PMSF) , pH 8.0 at 4°C.

After being

centrifuged at 27,000 g for 20 minutes at 4°C, the super
natant was collected.

The resulting pellet was resuspen

ded and centrifuged again.

The supernatants were pooled

and subjected to ammonium sulfate fractionation. Solid
ammonium sulfate (50 mg/mL) was added to the supernatant.
This was followed by stirring for 10 minutes.

The solu

tion was centrifuged and the supernatant recovered.
After additional ammonium sulfate (350 mg/mL) was added,
the supernatant was stirred for 1 hour at 4°C.

This was

followed by centrifugation, after which the pellet was
dissolved in a minimal amount of 10 mM
saline, pH 7.2 (PBS).

phosphate buffer

The solution was dialyzed over

night against 4 liters of PBS.

Protein concentration was

measured by the BCA Protein assay method (Pierce Chemical
Company) according to manufacturer1s suggested protocol
insert.
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b.

Immunization of Balb/c mice

i.

by conventional immunization method
To generate mouse hybrid cell clones secreting

monoclonal anti-human sperm antibody, a standard
technique was used as described elsewhere (Kohler &
Milstein, 1976).

Briefly, Balb/c mice (Jackson Laborato

ries, Bar Harbor, ME) were immunized subcutaneously (day
0) with human sperm surface proteins extracted by NP-40
(50 ug/animal) in complete Freund's Adjuvant, followed by
an intraperitoneal booster injection in incomplete
Freund's Adjuvant on day 21 and 28.

Mice with the high

est titer of antisperm antibodies [determined using the
enzyme-linked immunosorption assay (ELISA)] were given
intravenous or intraperitoneal injection (100 ug protein
in TBS) 4 days prior to fusion.

ii.

by tolerization of Balb/c mice with common antigenic
sugar moieties

Tolerogen:

A mixture of sugars (galactose + fucose +

mannose + N-acetylglucose) coated on glass beads.
Immunogen:

NP-40 extracted human sperm surface

antigens.
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Tolerization was accomplished by intraperitoneal
injection of sugar coated beads on weeks 0, 2, and 6.
After each tolerogen injection, cyclophosphamide at 1
mg/mL was injected intraperitoneally thrice (10 minutes,
24 hours and 48 hours after each tolerogen).
Immunization against NP-40 extracted sperm antigens
was accomplished by intraperitoneal injection, without
adjuvant, at 7.5 hours and 4 weeks later.

c.

Classical hybridoma technique to generate Mabs against
extracted sperm surface antigens
Immunized spleen cells were fused with mouse myeloma
cells (either SP2/0 or NS-1) in 3:1 ratio with 50% poly
ethylene glycol (PEG mol. wt. 1500).

After fusion, cells

were cultured in 96-well plates in selection medium
containing RPMI-1640 (Gibco Laboratories Inc. Logan, UT),
and HAT (Hypoxanthine, Aminopterin, Thymidine; Boehringer
Mannheim, GmbH, West Germany). Ten to fourteen days
after hybridization supernatant fluids from all wells
were screened for antisperm antibodies against swim-up
washed methanol fixed and swim-up washed motile human
sperm with an ELISA technique.

Positive hybridomas were

expanded and subcloned at least twice under limiting
dilution culture conditions (0.4 cells/wells).

Following

cloning, large amounts of culture supernatant were pro
duced in vitro, and ascites fluids containing antibodies
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were produced in vivo by intraperitoneal injection of 3-5
million hybridoma cells into balb/c mice 10 days after
priming with 0.5 mL of pristane (2,6,10,14-tetramethylpentadecane, Sigma Chemical Company, St. Louis, MO). A
flow diagram for production of anti-sperm MAbs is shown
in Fig. 8.

d.

Determination of class (isotype) and quantitation of
antibody
Antibody heavy- and light-chain classes were deter
mined using a mouse immunoglobulin subtype identification
kit (Zymed Laboratories, South San Francisco, CA). MAb
concentration in concentrated culture supernatant and
ascites were quantitated by isotype-specific single
radial immunodiffusion (Mancini et al., 1965) on stan
dardized plates (Tago, Burlinghame, CA).

SPECIFIC AIM NO. 2
Localization of antigens reacting with a particular MAb
restricted to the sperm surface

Immunofluorescence (IF)
To detect any cross reactivity of antisperm monoclonal
antibodies with human spermatozoa both immunofluorescence
(IF) (Hjort & Hansen, 1971) and immunochemical staining
(ICS) were performed.

For IF, swim-up human sperm were
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FIG. 8

A Flow Chart for Production of Monoclonal
Antibodies
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washed three times by centrifugation with PBS and placed on
teflon coated spot slides (Roboz, Washington, D.C.) at a
concentration of 5 million sperm/mL.

Slides were air dried,

fixed for 10 minutes in methanol and frozen at -70°C until
use.

The day that the test was performed, frozen slides

were thawed at room temperature and washed with PBS and then
blocked for 30 minutes with 10% normal goat serum, washed
again with PBS, and then incubated for 60 minutes at room
temperature or overnight at 4°C with serial dilutions of
antibody-containing ascites fluids.

The slides were then

washed in PBS, and further incubated for 60 minutes in the
dark at room temperature with fluorescein isothiocyanate
(FITC)— conjugated goat anti-mouse immunoglobulins (IgG,
IgA, and IgM; Cappel Laboratory, Cochranville, PA). After
three to four washings, the slides were mounted in mounting
media, a coverslip placed over the tissue, and then examined
under a Zeiss epifluorescence microscope.

The principle of

IF technique is shown in Fig. 9a.

Immunochemical staining (ICS)
ICS technique was performed by using the Zymed Histostain-sp kit (Zymed Immunohistochemical Kit, Zymed Laborato
ries, Burlingame, CA). This enzyme immunostain system can
be used in histochemistry and cytochemistry for localization
and visualization of antigens as surface markers.

The kit

utilized a biotinylated second antibody, a horseradish
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FIG. 9

A.

Principle of Indirect Immunofluorescence (IF)

B.

Principle of Immunochemical Staining (ICS)
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peroxidase-streptavidin conjugate and a substrate chromogen
mixture to demonstrate presence of the antigen in cells or
tissue.

The method of this staining system was as follows:

Briefly, the methanol fixed human sperm coated spot slides
were prepared the same way as described in IF technique
above.

Nonspecific background was eliminated by incubating

sperm with nonimmune serum.

The primary antibody to the

specific antigen was incubated to target antigens.

This was

followed by addition of a biotinylated second antibody which
served as the linker between the primary antibody and perox
idase-streptavidin conjugate.

The signal generating re

agent, streptavidin peroxidase was then added to bind to the
biotin residues on the linking antibody.

The presence of

enzyme was revealed by addition of a mixture of substratechromogen solution. The enzyme, peroxidase, catalyzes the
substrate hydrogen peroxide and converts it to chromogen,
aminoethyl carbazole to a red colored deposit which demon
strates the location of the antigen.

The principle of ICS

technique is shown in Fig. 9b.
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SPECIFIC AIM NO. 3
Determination of Molecular Weight of the Sperm Antigens by
Sodium Dodecyl Sulfate Poly Acrylamide Gel Electrophoresis
(SDS—PAGE) and Western Immunoblotting

To determine the molecular weight of sperm protein
recognized by antisperm antibodies, the Western
Immuno-blotting method was performed after SDS-PAG electro
phoresis of the human sperm NP-40 extract as described by
Laemmli et al. (1970).

Briefly, a discontinuous gel com

posed of a running gel (10% polyacrylamide; pH 8.8) and a
stacking gel (3% polyacrylamide? pH 6.8), both with 0.1%
SDS, were made.

Samples containing human sperm extract (100

ug protein) were diluted 1:1 with reducing sample buffer
(20% glycerol, 3% SDS, 12.5% 0.5M Tris-HCl pH 6.8, 5% 2mercaptoethanol, and 0.5% bromophenol blue) and boiled for 5
minutes.

The electrophoresis buffer chamber contained 25mM

Tris base, 0.19 M glycine, and 0.1% SDS.

Electrophoresis

was performed at 30 milliamps (constant current) at room
temperature with a circulating cold water cooling system.
Known pre-stained standards (BRL, Gaithersburg, MD) consist
ing of myosin, phosphorylase-B, bovine serum albumin, ovalbumin-chymotrypsinogen, B-lactoglobulin, and lysozyme with
apparent molecular weights of 200, 97, 68, 43, 25, 18, and
14 KD were also run.
Proteins from

the gels were electrophoretically trans

ferred to a 0.22 uM nitrocellulose membrane (Bio Rad
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Laboratories, Richmond, CA) by the blotting procedure of
Towbin et al., (1979).

In brief, the electrophoretic trans

fer of proteins was performed at 150 milliamps constant
current in transfer buffer (25mM Tris, pH 8.4; 192 mM gly
cine, 20% v/v methanol) overnight at room temperature.

Non

specific binding sites were blocked by incubating the nitro
cellulose membrane for 2 hours at room temperature with TBS
containing 0.1% Tween-20 (TBS-Tween) to remove excess BSA
and were allowed to react with individual monoclonal anti
body in a miniblotter-45 (Immunetics, Cambridge, MA) for 4
hours at room temperature.

After incubation> the nitrocel

lulose membrane was washed with TBS-Tween and incubated with
a 1:300 dilution of peroxidase-labeled rabbit anti-mouse
immunoglobulins for 1 hour at room temperature.

The excess

conjugate was removed by washing several times with TBSTween.

The enzyme bound to the nitrocellulose was visual

ized by adding freshly prepared substrate solution (30 mg of
chloronaphthol (Bio-Rad Laboratories, Richmond, CA) dis
solved in 10 mL methanol and diluted 1:4 with TBS, to which
hydrogen peroxide was added at a final concentration of
0.06%).

The reaction was terminated by washing the nitro

cellulose membrane with distilled water, followed by a 10
minute incubation and the reaction stopped with a stopping
solution (0.1% NaN3). The nitrocellulose blot was washed
again with distilled water and stored in distilled water
until photographed.
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SPECIFIC AIM NO. 4.
Determination of reactivity of MAbs with fresh, capacitated,
and acrosome reacted human sperm
A pool of swim-up human spermatozoa derived from normal
donors was divided in three groups.

The first group was

washed with PBS (used as fresh sperm), the second group was
incubated in BWW media 3-5 hours at 37 °C in a humidified 5%
C02 incubator (used as capacitated sperm), and the third
group was capacitated for 3-5 hours and then treated with a
10 uM calcium ionophore A23187 in dimethyl sulfoxide for 30
minutes (used as acrosome reacted sperm). After treatment,
sperm were washed three times by centrifugation with PBS and
reactivity of the MAbs with fresh, capacitated, and acrosome
reacted human sperm were determined by using ELISA and ICS
techniques.
Enzyme Linked Immunosorbent Assay (ELISA)
An indirect ELISA with whole sperm was used to screen
the culture supernatant and ascites fluids for antibody
activity.

Washed human sperm cells (2.5 x 105/well) were

resuspended in carbonate/bicarbonate buffer, pH 9.6, were
added to wells of 96-well plates, allowed to settle over
night at 4°C, and then methanol-fixed and stored at -70°C
until use.
Frozen coated plates were thawed and washed thrice with
PBS-Tween buffer to remove methanol and then blocked by
incubation for 30 minute with PBS containing 1% polyvinyl
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alcohol and 0.05% Tween-20 (Sigma) to remove any nonspecific
binding.

Culture supernatant or diluted ascites fluids as

primary antibodies were reacted overnight at 4°C in wells of
cell-coated plates.

The negative control (NS-1 myeloma cell

culture supernatant or ascites), a known positive control
and a blank (reagent buffer) were used with each plate to
validate the assay.

Unbound immunoglobulins were removed

during three washes with PBS-Tween buffer. Rabbit anti-mouse
immunoglobulins (IgG, IgA, IgM) conjugated with horseradish
peroxidase enzyme (Dako Chemical) were used as secondary
antibody and reacted with bound primary antibodies by incu
bating 60 minutes at 37°C.

After washing thrice with PBS-

Tween, the bound peroxidase activity was measured by adding
150 uL/well of orthophenyldinitro (OPD) diluted in 0.1 M
citrate buffer (pH 4.2, containing 0.03% hydrogen peroxide),
incubating 10 minutes at room temperature, and stopping the
reaction by adding 30 uL/well of 4 M sulfuric acid.

The

absorbance was read at 510 nM. The principle of sperm ELISA
technique is shown in Fig. 10.
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FIG. 10

Principle of Enzyme-linked Immunosorbent
Assay (ELISA)
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SPECIFIC AIM NO. 5
Determining whether these MAbs are against human sperm
surface antigens

To test whether these MAbs were reactive against sperm
membrane surface or internal antigens, these MAbs were
tested by ELISA and IBT (immunobead test) on live sperm.
For ELISA, swim-up washed human spermatozoa were incu
bated with MAb for 1 hour at 37°C in a humidified 5% C02
incubator, washed 3-4 times with PBS by centrifugation and
used to coat the sperm plate for ELISA.

Then a regular

ELISA technique was performed as described previously.
For the indirect immunobead test (IBT), semen from
normal fertile donors was processed to obtain the motile
fraction by swim-up technique.

The concentration of the

motile fraction was adjusted to 2 million motile sperm/mL
and incubated with the MAb for one hour at 37°C and 5% C02
in air and then excess antibody was removed by centrifuga
tion. Antibody coated sperm were mixed on a microscope slide
with rabbit anti-mouse immunoglobulins (IgG and IgM; Zymed,
San Francisco, CA) and the mouse Ig coated beads (polyacryl
amide beads conjugated with highly purified anti-mouse
antibodies of IgG and IgM class) and the motile sperm were
examined for number and location of beads attached.
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SPECIFIC AIM NO. 6
Evaluation of sperm specificity by cross-reactivity studies
of the newly generated panel

of Mabs

Washed human sperm cells (2.5 x 105/well) , red

blood

cells (2.0 x 105/well), Raji cells (1.5 x105/well), lympho
cytes (1.5 x 105/well) , and bacteria (5 x 105/well) were
resuspended in carbonate/bicarbonate buffer, pH 9.6, were
then added to wells of 96-well plates, allowed to settle
overnight at 4°C, and then methanol-fixed and stored at
-70°C until use.

To test any cross reactivity of antisperm

MAbs with these cells, regular ELISA was performed as
described previously.

SPECIFIC AIM NO. 7
Localize the origin of sperm antigens in the reproductive
system reacting with a particular MAb

To detect any cross-reactivity of antisperm monoclonal
antibodies with human reproductive tissue sections (pros
tate, epididymis, vas, seminal vesicle, testes), both
immunofluorescence (IF) (Hjort & Hansen, 1971) and immuno
chemical staining (ICS) were performed.

For IF, methanol

fixed frozen human reproductive tissue sections (available
in our laboratory stored at -70°C.) were washed in PBS and
then blocked for 30 minutes with 10% normal goat serum,
washed again with PBS, and then incubated for 60 minutes at
room temperature or overnight at 4°C with serial dilutions
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of antibody-containing ascites fluid.

The slides were then

washed in PBS, and further incubated for 60 minutes in the
dark at room temperature with fluorescein isothiocyanate
(FITC)- conjugated goat anti-mouse immunoglobulins (IgG,
IgA, and IgM; Cappel Laboratory, Cochranville, PA). After
three to four washings, the slides were mounted in mounting
media, a coverslip was placed over the tissue, and then the
slides were examined under a Zeiss epifluorescence micro
scope.
ICS technique was performed by using the Zymed Histostain-sp kit (Zymed Immunohistochemical Kit, Zymed Laborato
ries, Burlingame, CA) as described previously.

SPECIFIC AIM 8
Localization of antigens reacting with particular Mabs
restricted to human and other mammalian sperm surfaces

To detect whether or not these anti-human sperm antibod
ies cross-react with other animal sperm, methanol-fixed
sperm

(dog, mouse, rat, rabbit, monkey, hamster, bull,

baboon etc.) smears on spot slides were tested according the
sperm immunofluorescence (IF)/or immunochemical staining
(ICS) procedures as described previously.
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SPECIFIC AIM NO 9
Determine whether these antisperm antibodies have functional
significance
To evaluate whether antisperm antibodies to these anti
gens have any functional significance, sperm immobilization
tests, sperm agglutination tests, cervical mucus penetration
tests, hamster egg penetration tests, and hemizona tests
were done.

a.

Sperm Immobilization assay
Monoclonal antibodies were evaluated for their abili
ty to agglutinate and immobilize sperm with a modifica
tion of the methods described by Rose (Rose et al., 1976)
and the Isojima sperm immobilization test (Isojima et
al., 1968) respectively.

The agglutination and immobili

zation assays were run concomitantly.

For the immobili

zation test, swim-up washed human sperms were collected
and resuspended to 40 million motile sperm/mL in BWW
buffer pH 7.5.

An aliquot of normal guinea pig sera

(Cappel, Worthington, PA) was heat inactivated at 56°C
for 30 minutes to remove complement activity and the
assay was carried out in flexible flat bottom 96-well
plates.

Serial doubling dilutions of monoclonal antibod

ies were prepared for the immobilization assay by deliv
ering 20 uL normal guinea pig sera to 6 wells in the 96well tray and a parallel number of wells received 20 uL
62

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

of heat inactivated guinea pig sera.

Into the first well

of each series were delivered 20 uL monoclonal antibodies
and 20 uL was propagated through the next 5 wells to give
a 1:2 through 1:64 dilution series.

Two uL of sperm were

injected into each well and then all wells were covered
with 2 drops of liquid paraffin oil and placed in a 37°C
incubation chamber for 30 minutes.

A proven positive and

negative control ascites or serum diluted in saline were
used to validate each assay.

The sperm immobilization

was determined by using a normal light microscope and
immobilization values were recorded at which titer there
were 0-5% mobilization.

Fig. 11 illustrates the princi

ple of complement-dependent sperm cell lysis (immobiliza
tion) .

b.

Sperm agglutination assay
The sperm agglutination test was run employing a
similar scheme and similar materials.

In a 96-well

microtiter plate 12 series spots were prepared by adding
36 uL BWW to the first well and 20 uL BWW to all subse
quent wells.

Four uL of monoclonal antibodies were then

delivered to the first well and after mixing, 20 uL of
this mixture were propagated through the next 11 wells to
give a 1/10 doubling dilution series.

Two uL of sperm

were delivered to each well followed by an overlay of two
drops of liquid paraffin oil and

incubated 2 hours at
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FIG. 11

Principle of Complement-dependent Sperm
Cell Lysis (Sperm Immobilization Assay)
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37°C.

Titer of 1:20 or higher giving agglutination was

considered positive.

Microscopic examination of the

sperm also provided the information on the location of
the antibody binding on the surface, eg on the head,
tail, midpiece, or tail tip.

The Fig. 12 illustrates

some common sperm agglutination patterns.

c.

Cervical Mucus Penetration Test
The procedure as described by Serono Diagnostics for
the cervical mucus penetration assay (PENETRAK) was
modified for the assessment of antibody interaction.
Briefly, sperm

(60 x 106/ml) were treated for one hour

at 37°C in a humidified 5% C02 incubator with optimal
antibody titer (in the case of agglutinating antibodies
the same or one titer step beyond the agglutination titer
of the antibody was used). Then the normal protocol for
cervical mucus penetration was performed according to the
manufacturer's directions (Serono Diagnostics, Braintree,
MA) .

d.

Hamster Egg Penetration Assay (SPA)
The hamster egg penetration assay was used as an in
vitro method for assessment of the sperm ability to
undergo capacitation and the acrosome reaction, and to,
subsequently bind and penetrate the oocyte plasma mem
brane and then to undergo decondensation within the
65

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

FIG.

12

Sperm Agglutination Patterns

a. head-to-head
b. tail-to-tail
c. head-to-tail
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oocyte.

The SPA technique was originally reported by

Yanagimachi et al. (1976).

Our laboratory has modified

the procedure to test for the ability of antisperm
antibodies to affect capacitation events as well as to
post capacitation events.

In brief, human sperm were

incuba-ted with monoclonal antibodies during or after
their capacitation period.

All agglutinating MAbs were

papain digested to collect the Fab fragments according to
manufacturer's guidelines (Pierce, Rockford, IL) . The
medium used for handling sperm and oocyte prior to insem
ination was N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic-acid-buffered Biggers, Whitten, Whittingham
(BWW) medium supplemented with BSA (Sigma Chemical Compa
ny, St. Louis, MO); penicillin; and streptomycin.

Oocyt

es were obtained from mature hamsters given intraperitoneal injections of 40 IU of pregnant mare serum (Gestyl,
Organon, Holland) 2 hours after initiation of the light
phase of a 14:10 H light:dark cycle on the day of estrus
(day of ovulation). Fifty-six hours later, the hamsters
were injected IP with 40 IU of human chronic gonadotro
phin hCG, (Sigma Chemical Company, St. Louis, MO). On
the same day a fresh semen sample was collected and
allowed to liquify at 37°C for 30 minutes.

A one-half

milliliter aliquot of semen under 1 mL BWW was distribut
ed into 15 mL conical centrifuge tubes and incubated for
60-90 minutes at 37°C (swim-up procedure) . The BWW
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fractions were removed and evaluated for sperm motility
and grade of progression.

A sperm count was performed

and the concentration of the mixture was adjusted to
million sperm with BWW media.

10

Sperm were incubated

overnight in 5% C02 and humid air at 37°C as the

conical

centrifuge tube was resting at a 30-40° angle.
Oocytes from superovulated hamsters were then col
lected from the oviducts 15-16 hours after the hCG injec
tion.

The surrounding cumulus cells were removed by

treatment of the eggs with 0.1% hyaluronidase (Sigma
Chemical Company, St. Louis, MO) in BWW medium.
pellucida were removed by treatment with

0

The zona

.1 % trypsin in

BWW media (twice crystallized; Sigma Chemical Company,
St. Louis, MO). The zona-free oocytes were then passed
through five BWW washes to remove enzymes.
Concomitant with the egg processing, the sperm sam
ples were evaluated and adjusted to 3.3 million motile
sperm/mL of BWW media.

A 100 ul drop of sperm was placed

in a sterile plastic petri dish and covered with paraffin
oil; 20-3 0 oocytes in 50 uL were deposited in the sperm
drop (for a final concentration of 2.5 million motile
sperm/mL) and incubated at 37°C in 5% C02 in humid air
for 3 hours.

Oocytes were evaluated for penetration

after transfer of the eggs into fresh BWW medium to wash
excess sperm from the egg and then placement of

10

eggs

onto a slide (approximately 50 uL drop) and compression
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of the eggs under a 22 x 22 cm coverslip.

Penetration

was evaluated by phase-contrast microscope at 400X.

An

egg was considered fertilized when it contained at least
one swollen sperm head with an accompanying sperm tail.

e.

Hemizona Test (HZA)
The hemizona assay (HZA) has been used as a clinical
tool to evaluate patients and predict fertilizing poten
tial.

Overstreet et al. (1976) first suggested the use

of zona intact nonliving human oocyte to examine the
sperm-zona pellucida binding.

Researchers at our Insti

tute have further modified this technique by taking the
nonliving oocytes, cutting them in half by micromanipula
tion, removing the ooplasm and the two zona pellucida
almost identical halves called the "hemizona". These
halves are identical and therefore one half can provide
an excellent internal control for the examination of
various aspects of sperm-zona pellucida binding, a neces
sary prerequisite for human fertilization.

Our purpose

is to see whether the developed antisperm monoclonal
antibodies could block the sperm-zona attachment, and
thus prevent possible fertilization.
The procedure, as it is used for clinical testing,
has been described in detail elsewhere (Franken et al.
1989).

Briefly, human oocytes were obtained from cadaver

tissues or surgically excised ovarian tissue.

The
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oocytes were stored until use at 4°C in a solution of 1.5
M magnesium chloride with 0.1% polyvinyl pyrolidone (PVP,
MW 36,00) and 40 mM HEPES buffer to stabilize the pH at
7.0.

One day prior to use, the salt stored oocytes were

rinsed copiously in BWW supplemented with 0.35% BSA.

The

oocytes were cut in half using Narishige micromanipulator
(Narishige, Tokyo, Japan) mounted on a phase-contrast
microscope (Nikon Diaphot, Garden City, NY). The ooplasm
was removed by pipetting each hemizona through a finely
pulled pipette.

Each pair of hemizona was stored over

night in a droplet of medium under mineral oil.

The

following day, the hemizona were rinsed in Ham's F-10
supplemented with human fetal cord serum and incubated at
37°C and 5% C02 in air.

Semen specimens obtained from

healthy proven fertile donors, were overlayed with medium
to allow the sperm to swim-up into media.

The motile

fraction was collected and adjusted to a concentration of
0.5 million sperm/mL.

One of the pair of hemizona was

added to a control drop of sperm, while the other was
added to the experimental drop (swim-up motile sperm
incubated with specific monoclonal antibodies). After
incubation, each hemizona was rinsed in fresh medium to
dislodge loosely attached sperm, and the number of sperm
tightly bound to the surface of the zona pellucida was
counted.

A flow diagram of the hemizona assay is shown

in Fig. 13.
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FIG.

13

The Hemizona Assay (HZA) Flow Diagram
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SPECIFIC AIM NO. 10
Determine whether a carbohydrate moiety on the sperm surface
may be involved in antigen.
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To determine whether destruction of the carbohydrate
moieties on sperm surface could affect antibody binding,
human sperm aliquots were first treated with 0.5%, 1.0%, and
2

.0 % sodium meta-periodate solution and then the regular

ELISA technique was performed as described previously.

With

each monoclonal antibody a control assay (untreated sperm
ELISA) was also done to compare the percent of inhibition.

SPECIFIC AIM NO. 11
Determine whether a reduction in fertility occur in mice
in vivo.

Passive Immunization of Mice With Monoclonal Antibodies
The purpose of this experiment was to determine the
effects of passive immunization with monoclonal antisperm
antibodies on mouse fertilization in vivo.

The experimental

method was followed according to the protocol described by
Saling et al. (1985c). Briefly, female mice 5-8 weeks of
age were superovulated by the standard protocol.

At the

time both the PMSG and hCG injections were given, each
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female was given an additional IP injection of 0.5 mL
monoclonal antibody.

Following the hCG injection, the

females were housed with a male

(2

females and

1

male/cage). The following morning each female was checked
for vaginal plugs.

Only those females with vaginal plugs

were considered in the subsequent experiments.

Females were

sacrificed 40-44 hours post-hCG injection and their oviducts
were excised.

Normal fertilization was assumed to have

occurred when embryos (two cells or later stage) were recov
ered.

The number of embryos and the number of uncleaved

(one cell) oocytes were recorded.

Four different doses of

antibody were used (0.4, 1.0, 2.0, 4.0, mg/0.5 mL). The
number of mice at each dose were

6

females and 3 males; so

each test series involved 24 females and 12 males.
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CHAPTER 6

RESULTS

A total of five hybridizations were done by fusing
SP/O-Agl.4 or NS-1 mouse myeloma cells with splenocytes from
mice immunized with human sperm membrane antigens.

Two

extraction techniques were used for sperm membrane antigen
isolation.

In the first technique NP-40 detergent was used

for antigen extraction from a pool of swim-up washed human
spermatozoa collected from several donors.

In the second

technique mechanical homogenization of human testis was used
for antigen extraction.
Among the 130 hybrid cell clones secreting monoclonal
antisperm antibodies that were produced, 15 clones, based on
their sperm specificity, antibody titers, antibody class,
site of antigen recognition on the sperm surface, and the
molecular weight of their binding antigens, were selected
for further characterization.

These hybridoma cell lines

along with their antibody class (isotype) are given in
Table 1.

Eight out of fifteen were of the immunoglobulin

(Ig) M and seven were IgG class.

Among the seven IgG mono-

clonals; three were IgGi, three were IgG3, and one was IgGzb.
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TABLE 1

PROPERTIES OF FIFTEEN MONOCLONAL ANTIBODIES RAISED
AGAINST HUMAN SPERM SURFACE ANTIGENS

Mabs

Ag prep

DH3

NP-40

IgM

T,N, Ac

Sup. 68,25,14+/-

DH4

NP-40

IgM

T,N ,PA

Sup. 65,25

DH13

NP-40

IgM

T, PA

Sup.

>200

DH14

NP-40

IgM

T,N ,PA

Sup.

-

DH21

NP-40

IgM

N,PA,Eq

Asc. 68,45,37,23,14

DH22

NP-40

IgM

DH113

NP-40

IgG2b

Eq,N ,PA

Sup. 65,50,14

DHF5

NP-40

Igc3

T, PA

sup. 65,50

DH200

NP-40

IgG3

WS

Sup.

DH201

NP-40

IgGi

T, PA

Sup. 14

DH202

NP-40

IgGi

H

Sup. 14

DH203

NP-40

IgG3

Ac,T

Asc.

DH205

NP-40

IgG,

H(rim),Eq,T

Sup. 14,20-25

DHTB11

Testicular IgM
extract

N, PA

Sup. 65

DHTol
P3C9

NP-40

N, PA

Sup.

Ab Class

IgM

Ag location

PA,T,N,Eq(+/-)
*[Ac,PA,T(+/-))

Mol Wt. KD

Asc. 68,14+/-

-

-

68,

65

T(tail), Ac(acrosome), N(neck), PA(postacrosome) , H(head), WS(whol
sperm), Eq(equatorial), Sup(culture supernatant), Asc(ascities)
Mabs(monoclonal antibodies)
* on acrosome reacted sperm
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Antigen localization

The locations of antigens recognized by the Mabs were
examined using immunofluorescence (IF) and immunochemical
staining (ICS) of methanol-fixed sperm from humans (Table
1).

The fifteen antibodies all showed staining when biotin-

avidin ICS and IF staining procedures were employed.

These

monoclonals often appeared to bind to multiple sites on
human sperm.

DH3 reacted with tail, neck, and acrosome

regions; DH200 reacted with whole sperm; DH201 with tail and
post-acrosome; whereas DH202 reacted with the entire head
region of sperm.

Among the others, DH4 and DH14 reacted

with the tail, neck, and post-acrosome; DH13, DH201, and
DHF5 with the tail and post-acrosome; DH21 with the neck,
post-acrosome and equatorial region; DH22 with the postacrosome, tail, neck, and equatorial (some) of non-acrosome
reacted sperm and acrosome, post-acrosome, and tail (+/-) of
acrosome reacted sperm; DH113 with the equatorial, neck, and
post-acrosome; DH203 with the acrosome and tail; DH205 with
the head rim, equatorial and tail; DHTBn and DHT0 IP3C9 with
the neck and post-acrosome region of human spermatozoa.
Some of these MAb binding patterns with human sperms are
shown in Fig. I4(a-g).
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F IG .

14

a.

Antisperm MAb DH14 bound to postacrosome,
neck and tail of human sperm (by IF).

b.

Antisperm MAb DH22 bound to acrosome, post
acrosome, and tail (+/-) of acrosome-reacted
human sperm (by IF).

c.

Antisperm MAb DH22 bound to postacrosome,
equatorial (+/-), neck, and tail of fresh
(not acrosome-reacted) human sperm (by IF).
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b.

c.
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FIG.

14

d.

Antisperm MAb DH13 bound to postacrosome and
tail of human sperm (by ICS).

e.

Antisperm MAb DHTBn bound to postacrosome
and neck of human sperm (by ICS).

f.

Antisperm MAb DH202 bound to the entire head
of human sperm (by ICS).

g.

Antisperm MAb DH200 bound to all regions of
human sperm (by ICS).
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f.

g.
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Molecular Weight of Corresponding Antigens

These monoclonal antibodies revealed multiple bands
by immunoblotting procedures.

DH3 and DH4 recognized anti

gens having apparent molecular weights of
addition to the
KD region.

68

68

and 25 KD. In

and 25 KD bands, DH3 also recognized a 14

DH13 recognized antigens with a 273 KD, and DH21

recognized

68

, 45, 37, 23, and 14 KD bands.

nized two bands,

68

DH 22 recog

and 14 KD, DH 113 recognized three bands

of 65, 50, and 14 KD, DHF5 and DH201 each recognized one
band of 14 KD, and DH205 recognized two bands of 20 and 14
KD.

Immunoblot of antisperm MAbs binding to sperm protein

extract is shown in Fig. 15.

Reactivity of the Monoclonals with Fresh, Capacitated, and
Acrosome Reacted Human Sperm by ELISA and ICS

Reactivity of the monoclonals with fresh, capacitated,
and calcium ionophore treated (acrosome reacted) human sperm
was evaluated by ELISA and ICS.
Table 2.

The results are shown in

One monoclonal, DH22, showed higher reactivity

with acrosome reacted spermatozoa than to fresh and capaci
tated human spermatozoa.

All others showed higher reactivi

ty with fresh and capacitated spermatozoa in contrast to
acrosome reacted human spermatozoa.
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FIG. 15

Immunoblot of antisperm MAbs binding to NP-40 extract
proteins of human sperm. Sperm extract was electrophoresed under reduced conditions.
Lane 1

Known molecular weight markers of lysosome,
14KD; beta lactoglobin, 18KD? alpha chymotrypsinogen, 25KD? ovalbumin, 43KD; bovine serum
albumin, 6 8 KD; phosphorylase b, 97KD; and
myosin 200KD.

Lane 2
Lane 3

Antisperm MAb DH3 recognized 6 8 , 25, and 14
KD.
Antisperm MAb DH4 recognized 65 and 25 KD.

Lane 4

Antisperm MAb DH13 recognized >200 KD.

Lane 5

Antisperm MAb DH14 did not recognized any
protein band.

Lane

6

Antisperm MAb DH21 recognized
and 14 KD.

68

Lane 7

Antisperm MAb DH22 recognized

68

Lane

Antisperm MAb DH113 recognized 65, 50, and 14
KD.

8

, 45, 37, 23,
and 14 KD.

Lane 9

Antisperm MAb DHF5 recognized 65 and 50 KD.

Lane 10

Antisperm MAb DH200 did not recognized any
protein band.

Lane 11

Antisperm MAb DH201 recognized 14 KD.

Lane 12

Antisperm MAb DH202 recognized 14 KD.

Lane 13

Antisperm MAb DH203 did not recognized any
protein band.

Lane 14

Antisperm MAb DH205 recognized 14 and 20-25
KD.

Lane 15

Antisperm MAb DHTB11 recognized 65 KD.

Lane 16

Antisperm MAb DHTolP3C9 recognized
KD.

68

and 65
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TABLE 2

REACTIVITY OF MONOCLONAL ANTIBODIES WITH FRESH,
CAPACITATED, AND ACROSOME REACTED
SPERMATOZOA

MAbs

Fresh
ELISA/ ICS

Capacitated
ELISA/ ICS

DH3
DH4
DH13
DH14
DH21
DH22
DH113
DHF5
DH200
DH201
DH202
DH203
DH205
DHTB11
DHTolP3C9

++/
++/
++/
++/
++/
++/
++/
++/
++/
++/
++/
++/
++/
++/
++/

++/ Eq,T
++/ T,N
++/ WS
++/ WS
++/
++/PA,T,N,Eq
++
++/ T,PA
++/ N,Eq
++/ WS
++/
++/ H
++/ Eq,T
++/ Eq,T
++/

T,N ,Ac
T,N ,PA
T,PA
T, PA
Eq,PA,N
PA,T,N,Eq
Eq,PA,N
T,PA
WS
T,PA
H
Ac,T
H,T
PA,N
PA,N

Acrosome reacted
ELISA/ ICS
+/ T*,Eq*
+/ T*,N*
+/ T*,Eq*
+/ WS*
+
+++/ Ac,PA,T,N,
+/
+/ +/ "
+/ +/
+/T,H*
+/+/
+/

+
optical density 2-3 times above background
++
optical density 8 - 1 0 times above background
+++ optical density > 1 0 times above background
Fresh swim-up washed human sperm coated on spot slide and air
dried
Capacitated swim-up sperm with BWW media incubated overnight at
37°C, 5% C02 then washed and coated on spot slide and air dried.
Acrosome-reacted
swim-up sperm with BWW media and calcium
ionophore are incubated overnight at 37°C, 5% C02 then washed and
coated on spot slide and air dried.
ELISA Enzyme Linked Immuno Sorbant Assay
ICS
Immunocytochemical Staining
* Faint staining
Ac(acrosome), Eq(equatorial), H(head), N(neck), PA(postacrosome),
T(tail), WS(whole sperm)
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Studies on Surface vs Internal Antigens

To test whether these Mabs are reactive against the
sperm membrane surface or internal antigens, we tested them
with a live sperm ELISA and with immunobead assays
(Table 3 ).

All of the fifteen MAbs showed positive binding

with live sperm.

Selecting antibodies which reacted only to

surface antigens was one of the goals of our study.

Specificities of Monoclonal Antisperm Antibodies
Sperm specificity of these monoclonal antibodies was
investigated by ELISA with white blood cells (WBC), red
blood cells (RBC), lymphoblastoma (LBO) cell line, bacteria,
human seminal plasma, human albumin, and human lactoferrin.
As shown in Table 4, none of these monoclonals reacted with
either WBC, RBC, LBO, bacteria, human albumin, or human
lactoferrin.

DH 200-203 slightly and DH205 moderately

reacted with seminal plasma.
Cross reactivity of these monoclonals with various
frozen human somatic tissue sections (myometrium, adrenal,
thyroid, liver, lungs) was investigated by immunofluores
cence and immunochemical staining.
Table 4.

Results are shown in

None of these monoclonals reacted with any of

these human somatic tissue sections tested.
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TABLE 3

MAbs
DH3
DH4
DH13
DH14
DH21
DH22
DH113
dhf5
DH200
DH201
DH202
DH203
DH205
DHTBn
DHT0 IP3C9

STUDIES ON SURFACE VS INTERNAL ANTIGENS

Live sperm ELISA
++
++
++
++
++
++
++
++
++
++
++
++
++
++
++

Immunobead Test (IBT)
N, T
N,T
H, T
H, T
H, N
H, T
H, N
H, T
H, T
T
H
H, T
H, T
H,N
H,N

++ 8 - 1 0 times above background
H (head), N (neck), T (tail)
ELISA (enzyme-linked immunosorbant assay)
MAbs (monoclonal antibodies)
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TABLE 4
MAbs

SPECIFICITY OF ANTISPERM MONOCLONAL ANTIBODIES

WBC

RBC

LBO

Bact.

Hu Sem.

lacto.

HU.
Alb

Plasma

DH3

-

- *

- *

-

-

—

-

DH4

-

- *

- *

-

-

-

-

DH13

-

- *

- *

-

-

-

-

DH14

-

- *

- *

-

-

-

-

DH21

-

- *

- *

-

-

-

-

DH22

-

- *

- *

-

-

-

-

DH113

-

- *

- *

-

-

-

-

DHF5

-

- *

- *

-

-

-

-

DH200

-

-

- **

-

+/-

-

-

DH201

-

-

-

+/-

-

-

DH202

-

-

- **

-

+/-

-

-

DH203

-

-

- **

-

+/-

-

-

DH205

-

-

- **

-

+

-

-

DHTB11

-

-

*

-

**

-

-

-

-

DHTol
P3C9

—

-

*

-

**

-

-

-

-

**

-

hybridoma supernatant tested as 1 : 1 0 0 dilution
** hybridoma supernatant tested as 1:50 dilution (all other
tests were done as neet by using hybridoma supernatant)
+/- when ELISA optical density twice than negative control
WBC (white blood cell), RBC (red blood cell),
LBO (lymphocyte), Bact (bacteria staphylococci, streptococci,
salmonella, klebsiella), lact. (lactoferrin), Alb. (human
albumin)
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Localization of Antigenic Epitopes Corresponding to MAbs in
Reproductive System

To determine the possible origination of the antigenic
epitopes corresponding to these MAbs in the reproductive
system, immunofluorescence and immunochemical staining
techniques were used for staining human frozen testes,
epididymis (caput, corpus, cauda) vas, seminal vesicle, and
prostate tissue sections (Table 5).

DH3, DH113, DH200-203,

and DHTBn bound to spermatozoa and spermatid in the testis;
DH4, DH14, and DH205 bound to epithelium of the seminal
vesicle; DH13, DH21, DH22 and DHF5 bound to glandular
epithelium of the cauda and sperm in the cauda; and DHTolP3C9 bound to sperm in the testes, the epididymis (caput,
corpus, and cauda), and the vas defferens.

Some of these

MAbs binding patterns on different tissue sections are shown
in Fig. 16 (a-h).

Cross-Reactivity of Monoclonal Antibodies With Other
Species' Spermatozoa

Reactivity of these antisperm monoclonal antibodies with
other species' spermatozoa (monkey, dog, rabbit, mouse, rat,
and bull) was done by immunochemical staining and immunoflu
orescence study (results are shown in Table

6

).

Most of

these monoclonal antibodies showed reactivity with sperm of
several species; DH 3 reacted with all species tested except
monkey sperm; DH4 with dog and bull sperm; DH13 reacted with
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TABLE 5
CROSS REACTIVITY STUDY AGAINST HUMAN TISSSUES OF ANTI
HUMAN SPERM MONOCLONAL ANTIBODIES BY
IMMUNOFLUORESCENCE STUDY
Testes

Caput

Cauda

-

+

-

-

-

-

-

-

-

-

-

-

+

-

-

-

-

-

+

-

-

-

-

-

-

-

-

-

-

+

-

-

-

-

-

-

-

+

-

-

-

-

-

-

-

-

-

-

+

-

-

D H 113

-

-

-

-

-

-

+

-

-

-

-

DH F5

-

-

-

-

-

-

-

+

+

-

-

D H 200

-

-

-

-

-

-

+

-

-

-

-

D H 201

-

-

-

-

-

-

+

-

-

-

-

D H 202

-

-

-

-

-

-

+

-

-

-

-

D H 203

-

-

-

-

-

-

+

-

-

-

-

D H 205

-

-

-

-

-

-

-

-

-

-

+

D H TB 11

-

-

-

-

-

-

+

-

-

-

-

—

-

-

-

-

+

+

+

+

-

Myomet

Liver

Prost

DH3

-

-

-

-

-

DH4

-

-

-

-

D H 13

-

-

-

D H 14

-

-

D H 21

-

D H 22

TolP3C9 -

Adren

Thyroid

MAbs

Lungs

Vas

prost(prostate gland), myomet(myometrium), adren(adrenal
gland), sem(seminal vesicle)
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sem

FIG.

16

a.

Antisperm MAb DHF5 bound to caudal region of
human epididymis (by IF) .

b.

Antisperm MAb DH13 bound to caput region of
human epididymis (by IF) .

c.

Antisperm MAb DHP3C9 bound to caput region
of human epididymis (by IF).
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FIG.

16

d.

Antisperm MAb DH4 bound to human seminal
vesicle components (by IF).

e.

Antisperm MAb DH14 bound to human seminal
vesicle components (by IF) .

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

FIG.

16

f.

Antisperm MAb DH3 bound to human testis
components (by IF).

g.

Antisperm MAb DHT0 IP3C9 bound to human
testis components (by IF).
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FIG.

16

h.

Antisperm MAb DHTBn bound to human testicu
lar spermatozoa and spermatids (by IF) .
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TABLE 6

REACTIVITY OF ANTI-HUMAN SPERM MONOCLONAL
ANTIBODIES WITH DIFFERENT SPECIES SPERM BY
IMMUNOCHEMICAL STAINING (ICS) STUDY

Dog

MAbs

Monkey

DH3

-

Ac, N

DH4

-

AC

DH13

Ac,T

Ac, T

Rabbit

Mouse

AC

Ac,T

-

-

Ac,T

Ac, T

Rat

Bull

WS

Ac

-

Ac

ND

Ac

DH14

-

Ac

Ac+/—

-

-

Ac

DH21

-

Ac

-

-

-

Ac

DH22

Ac,Eq,T

-

ND

Ac,N

ND

Ac

DH113

ND

Ac

ND

ND

ND

Ac

DHF5

-

ND

Ac

T

Mp

Ac

DH200

-

-

-

T

ND

Ac

DH201

Ac

Ac

Ac

Ac

ND

Ac

DH202

Eq,T

-

Ac,N,Mp

H

-

Ac

DH203

Ac

-

Ac

H

-

Ac,T

DH205

-

Eq

ND

-

-

ND

Ac,Eq

Ac,N

T

Ac,Mp

ND

Ac,Mp

DHTBn

-

DHT0 IP3C9 Ac,T
(-)control

“

Mp
AC(tip),
Mp

Ac,N
Ac,Mp

—

Ac(Acrosome), E q (equatorial), N(neck), T(tail),
Mp (midpiece), H(head), ND(notdone)
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all species' sperm; DH14 reacted with dog, rabbit, and bull
sperm; DH21 reacted with dog and bull sperm.

DH22 reacted

with all except dog sperm; DH113 and DHF5 reacted with
rabbit, mouse, rat, and bull sperm; DH200 with mouse and
bull sperm; DH201 reacted with all species' sperm; DH202 and
DH203 reacted with all except dog and rat sperm; DH 205
reacted with dog and bull sperm; and DHT0 IP3C9 reacted with
monkey, dog, mouse, rat, and bull sperm.

Some of these MAbs

binding patterns with different species' sperm are shown in
Fig. 17 (a-k).

Sperm Agglutination And Immobilization Assay
To see whether any inhibition of sperm functional tests
(SA/SI) can occur by these monoclonal antibodies, micro
sperm agglutination and immobilization assays were done
(data shown in Table 7a). Among fifteen monoclonal antibod
ies; DH200, DH201, DH202, and DH203 caused agglutination and
DH200, DH202, and DH203 immobilized human spermatozoa in the
presence of complement.

Furthermore, these same four mono-

clonals caused agglutination and immobilization of mouse
spermatozoa (Table 7b). The pattern of agglutination was
chain with DH200, cluster with DH201 and DH202, and mixed
with DH203.
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FIG.

17

a.

Antisperm MAb DHT0 IP3C9 bound to acrosome
and xnidpiece of bull sperm (by ICS) .

b.

Antisperm MAb DH3 bound to acrosome of bull
sperm (byICS).

c. Antisperm MAb DH13bound
sperm (byICS) .

toacrosome

of bull

d. Antisperm MAb DHTBn bound to acrosome and
neck of rabbit sperm (by ICS).
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FIG.

17

e.

Antisperm MAb DHTBn bound to midpiece of
rat sperm (by ICS).

f.

Antisperm MAb DH3 bound
rat sperm (by ICS).

g.

Antisperm MAb DH3 bound to acrosome and tail
of mouse sperm (by ICS).

h.

Antisperm MAb DHT0 IP3C9 bound to acrosome
and midpiece of mouse sperm (by ICS).

to allregions of
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FIG.

17

i.

Antisperm MAb DH3 bound to acrosome and neck
of dog sperm (by ICS).

j . Antisperm MAb DH202 bound to acrosome, neck,
and midpiece of rabbit sperm (by ICS).
k.

Antisperm MAb DH203 bound to acrosome of
monkey sperm (by IF).
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TABLE 7a

REACTIVITY OF MONOCLONAL ANTI-HUMAN SPERM ANTIBODIES IN
SPERM IMMOBILIZATION AND SPERM AGGLUTINATION ASSAYS WITH
HUMAN SPERM
MAbs
DH3
DH4
DH13
DH14
DH21
DH22
DHF5
DH113
DH200
DH201
DH202
DH203
DH205
DHTBn
DHT0 IP3C9

Agglutination

Immobilization
-

-

-

-

-

-

-

-

-

-

-

-

-

-

>20480
>20480
>20480
>20480

>64
-

16
>64
-

(chain)
(cluster)
(cluster)

(mixed)

-

-

-

-

-

TABLE 7b
REACTIVITY OF MONOCLONAL ANTI-HUMAN SPERM ANTIBODIES IN
SPERM IMMOBILIZATION AND SPERM AGGLUTINATION ASSAYS WITH
MOUSE SPERM
MAbs
DH3
DH13
DH22
DHF5
DH200
DH201
DH202
DH203
DHTBn
DHT0 IP3C9

Immobilization

Agglutination

_

_

-

-

-

-

>64
>64
>64
>64
-

-

>20480
>20480
20480
>20480
-

—

“

- (negative), 64 (at 1:64 dilution), 20480 (at 1:20480
dilution)
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Hamster Egg Penetration Assay
The ability of these antisperm monoclonal antibodies to
prevent human spermatozoa to penetrate zona free hamster
oocyte was investigated and results are given in Table

8

.

Among these fifteen monoclonals, DH3, DH13, DH14, DH22,
DH205, and DHTo1P3C9i significantly inhibited hamster egg
penetration. Only DH3 and DH13 inhibited human sperm pene
tration of zona free hamster eggs when treated with pre
capacitated sperm but not post-capacitated sperm.

On the

other hand, MAb DH22 showed stronger inhibition when incu
bated with post-capacitated sperm.

Hemizona Assay
The hemizona assay (sperm functional test) was done with
MAbs to evaluate inhibition of sperm egg attachment due to
binding of these antibodies.
assessed for each MAb.

Two to four hemizona were

These MAbs were also sent to another

laboratory (Jane Rogers, Vanderbilt University, TN) to
repeat the assay and to confirm the test results.

A hemi

zona index (HZI) calculated by counting the number of tight
ly bound sperm on the test zona and dividing by the number
of tightly bound sperm on control zona.

This number was

multiplied by 100 to obtain the percentage.

A HZI of less

than 50% was considered to represent significant inhibition
of sperm egg attachment probably due to the presence of
antisperm antibodies.

Of the 15 MAbs tested, 7 inhibited
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TABLE 8

ZONA FREE HAMSTER EGG PENETRATION ASSAY**
(SPA)

SPA
PI
%lnhib.

Normal Donor
100 %
4.5
0%

DH3
34%, *92%
0.55, 3.5
66 %
8%

DH4
78%,*88%
1.6, 5.2
2 2 %,*12 %

NS-1
100 %

SPA
PI
%Inhib.

Normal Donor
92%
3.6
8%

DH13
30%, *90%
0.4, 2.5
70%, *10%

DH14
32%,*25%
1.25
68 %,*75%

NS-1
100 %
4.5
0%

DH22
56% *25%
0.87
44%,*75%

dhf5
66 %
0.83
34%

NS-1
93%
3.5
7%

DH201
71%

NS-1
86 %

SPA
PI
%Inhib.

Normal Donor
10 0 %
3.0
0%

SPA
PI
%Inhib.

Normal Donor
10 0 %
3.0
0%

DHT0 IP3C9
42%
0.5
56%

SPA
PI
%Inhib.

Normal Donor
95%
3.3
5%

SPA
PI%
%Inhib.

Normal Donor
100%
5.7
0%

6.6
0%

1.1

29%

14%

DH21
54%
0.75
46%

DH205
59%
0.95
41%

NS-1
96%
3.8
4%

DH203
75%

DH113
70%
0.95
30%

1.2

25%

NS-1
93%
3.5
7%

* short preincubation in presence of antibody (1.5 hour)
no. of eggs penetrated x 1 0 0
SPA% (percent of sperm penetration) = -----------------no. of eggs inseminated
total no. of swollen head
PI (penetration index) = ---------------------no. of egg inseminated
%Inhib. (percent of inhibition) = 100 - %SPA
** Some of these MAbs were sent to another laboratory (Jane
Rogers, Vanderbilt University, TN) for SPA to confirm the
test results
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tight binding by at least 50% (Table 9) . Eight MAbs did not
significantly reduce sperm binding, although the average
number of sperm bound was decreased compared to the control.

In Vitro Cervical Mucus Penetration Assay

In vitro cervical mucus (CM) penetration tests were
conducted to examine whether any inhibition of penetration
occurs due to antibody binding to sperm.

A significant

reduction of penetration was considered when the distance of
penetration was less than 20 mm.

None of these MAbs impeded

sperm CM penetration (Table 10) .

Determination of Whether a Carbohydrate Moiety was involved
on the Sperm Surface

Destruction of carbohydrate components on the sperm
surface was done by treating methanol-fixed sperm with
sodium metaperiodate; then ELISAs were performed by the
usual procedure and the effect of damage to carbohydrate
antigen on MAb binding was examined (Table 11).

A concen

tration dependent response to periodate oxidation was ob
served with three MAbs (DH200, DH202, and DH203), although
the antigenicity of these MAbs was retained in some degree.
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TABLE 9

HUMAN SPERM/ZONA TIGHT BINDING TEST:
HEMIZONA ASSAY (HZA)

MAbs

HZAa indexb

HZA inhibition

INHIBITORS
OF ZONA
BINDING0

DH3
DH4
DH13
DH14
DH21
DHTB11
DH205

19%
27%
17%
46%
41%
40%
33%

81%
73%
83%
54%
59%
60%
67%

NONINHIBITORS
OF ZONA
BINDINGd

DH22
DHF5
DHTolP3C9
DH113
DH200
DH201
DH202
DH203

80%
66%
53%
57%
80%
84%
85%
71%

20%
34%
47%
43%
20%
16%
15%
29%

a The hemizona assay-two to six pairs of HZ were assessed
for each MAb
no. of tight bound sperm on test zona x 1 0 0
bHZI(hemizona index) ---------------------------------no. of tight bound sperm on control zona
c INHIBITING: HZI< 50
d NONINHIBITING: HZA> 50
These MAbs were also sent to another laboratory (Jane
Rogers, Vanderbilt University, TN) to repeat the HZA assay
and to confirm the test results.
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TABLE 10

MAbs

IN VITRO CERVICAL MUCUS PENETRATION ASSAY

Ig class

DH3
DH4
DH13
DH14
DH21
DH22
DHF5
DH113
DH200
DH201
DH202
DH203
DH205
DHTB11
DHT01P3C9
♦Control

IgM
IgM
IgM
IgM
IgM
IgM
IgG3
igG2b
lgc3
igGi
IgGi
IgG3
IgGi
IgM
IgM
-

Distance penetrated**
33mm
25mm
25mm
27mm
45mm
2 2 mm
25mm
25mm
25mm
25mm
25mm
25mm
26mm
26mm
25mm
30mm

* sperm incubated with ascites from NS-1 (non-antibody
secreting cell line) and used as negative control.
** distance penetrated >25mm means no inhibition.
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TABLE 11
PERCENT OF INHIBITION OF ANTI-HUMAN SPERM ANTIBODIES BINDING
AFTER DESTRUCTION OF CARBOHYDRATE MOIETY ON SPERM MEMBRANE
BY
TREATING SPERM WITH SODIUM-META-PERIODATE

MAbs

DH3
DH4
DH13
DH14
DH21
DH22
DH113
DHF5
DH2 00
DH2 01
DH202
DH203
DH205
DHTB11
DHTolP3C9

I
N
Untreated
control
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%

H

I

lOmM

100

-

I
T
I
0
Treated
25nM
lOOmM
50mM

0%
0%
0%
0%
0%
0%
0%
0%

0%
0%
0%
0%
0%
0%
0%
0%

18%
0%
70%
13%
0%
0%
0%

28%
0%
80%
39%
0%
0%
0%

100

% inhibition =

B

0%
0%
0%
0%
0%
0%
0%
0%
68%
0%

84%
40%
0%
0%
0%

N
200mM

0%
0%
0%
0%
0%
0%
0%
0%

0%
0%
0%
0%
0%
0%
0%
0%

84%
0%
86%
63%
0%
0%
0%

84%
0%
86%
63%
0%
0%
0%

x test. O.D

------ ------- --------

control O.D
[Three separate assays were done and MAbs ran in duplicate
in each time, then average of all test results was taken for
percent of inhibition calculation].
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Passive Immunization

Two MAbs were selected for a passive immunization in
order to evaluate whether they reduced fertility in mice.
These two antibodies were selected for passive immunization
experiment based on their cross reactivity with mouse sperm,
location of reacting antigens on sperm, and inhibition of
any other sperm functional tests in vitro (sperm immobiliza
tion and sperm agglutination). No significant reduction of
fertility was found compared to control (Table 12).
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TABLE 12
MAbs

IN VIVO SPERM FUNCTIONAL TEST:
PASSIVE IMMUNIZATION

Ag location
human/ mouse

SA/SI
human

DH201

T

/ Ac

+ /-

DH203

Ac,T

/ H

+ /+

SA/SI
mouse
+/+

+/+

Passive Immunization
fertility inhibition
no significant
inhibition compared
to control

no significant
inhibition compared
to control

T(tail), Ac(acrosome), H(head), SA/SI(sperm agglutination
assay/sperm immobilization assay), Ag(antigen)
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CHAPTER 7

DISCUSSION

In this study, splenic plasma cells from immunized mice
producing human antisperm antibodies were successfully fused
with myeloma cells to produce monoclonal antibodies (MAbs).
Two extraction techniques were used for sperm membrane
antigen isolation.

The first technique involved NP-40

detergent for antigen extraction from swim-up (motile frac
tion) human ejaculated sperm and the second technique em
ployed homogenized human testis for antigen extraction.

We

used pooled ejaculates from several normal human donors for
antigen extraction procedures to reduce some possible indi
vidual variations of sperm membrane components.

Swim-up

sperm were all motile and likely to be those sperm associat
ed with fertilization. By using swim-up washed sperm rather
than only washed sperm, we did eliminate some non-motile
sperm and also a population of round cells, including germ
cells and white blood cells which are not important for
fertilization but present in ejaculates of normal men.
Another comparison study from our laboratory (Gupta et al.,
1990) suggested that swim-up sperm rather than thrice-washed
sperm are far more appropriate for studies of sperm antigens
associated with motile sperm.
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The results of ELISA and immunobead tests (both on live
sperm) indicated that we successfully isolated human sperm
membrane surface antigens from these extraction procedures,
and by using these extracts as immunogens, we developed some
sperm membrane specific monoclonal antibodies.

The human

testicular antigen extraction procedure used in this study
for immunizing mice also showed a promising approach for
developing antisperm MAbs.

The one advantage of these MAbs

is that since they reacted with testicular sperm, as well as
ejaculated sperm, they can be used in the cDNA testis li
brary available for large scale preparation of corresponding
antigen for contraceptive vaccine development.
The results of the immunofluorescence and immunochemical
staining studies on methanol-fixed sperm indicated that
these antibodies recognized antigens on the plasma membrane
overlaying different regions of the sperm. It has been
reported by many researchers (Hansen and Hjort, 1971;
Jeffery and Parish, 1972) that naturally occurring human
antisperm antibodies bind to antigens located on the acro
some, post-acrosome, equatorial, midpiece, and tail.
study also indicated the same profile.

Our

Since sperm acro

somal region plays the central role in sperm-egg interac
tions, acrosomal antigens seemed of greatest importance.
Three MAbs (DH3, DH22, and DH203) developed in this study
reacted to sperm acrosomal antigens and among these MAbs,
two (DH3 and DH22) impeded sperm-egg interactions.
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When these antisperm monoclonal antibodies were subjected
to immunohistological and immunofluorescence evaluations
against an extensive panel of human tissues or cells, no
cross-reactivity to somatic tissues was observed.

Most of

the antisperm antibodies with sperm functional inhibitory
properties reported by many researchers have cross-reacted
with some human somatic tissues or cells and therefore are
disqualified for contraceptive vaccine use.

The absence of

cross-reactivity to somatic tissues with MAbs developed in
this study meet one of the important criteria of a primary
candidate for contraceptive vaccine development as estab
lished in a WHO workshop.
Human reproductive tissue sections treated with our
various antisperm MAbs were tested by employing IF and ICS.
Staining was found on spermatozoa and spermatids in the
testis; on epididymal epithelium and the sperm in caput-,
corpus-, and cauda epididymis; components of seminal vesi
cle; and sperm in the vas deferens.

This gives us informa

tion as to the possible origination of these corresponding
antigens in the human reproductive system.

It has been

reported (Myles and Primakoff, 1983; Phelps and Myles, 1987)
that even as early as in the testis, some antigenic sites
are localized by observing antibody binding to the whole
cell, whole head, anterior tail, and posterior tail.

Eddy

(1990) and Cameo et al. (1990) reported that surface sites
and molecules of defined sperm surface domains are complex.
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Binding can occur at different times and perhaps via
different mechanisms.

Also, these arrangements are not

static but can be altered at different stages in sperm
maturation.

Rearrangements of surface molecules can occur

as a result of external signal and include the creation or
uncovering of new epitopes on preexisting surface molecules.
Our data showed that DH13, DH21, DH22, and DHF5 reacted with
the epididymal factors and that DH4, DH14, and DH2 05 reacted
with the seminal vesicle factors.

DH3, DH113, DH200-203,

and DHTB11 recognized testis originated antigens but did not
recognize any epididymal factors.

These testicular antigens

were probably altered or masked at different stages of
epididymal sperm maturation and then unmasked again on
ejaculated sperm.

On the other hand, DHTolP3C9 did bind to

a testicular originated antigen, but the antigen appeared to
remain unchanged during different stages of sperm matura
tion.
When species cross-reactivity was assessed for a variety
of other species' spermatozoa, six MAbs cross-reacted with
monkey sperm and all MAbs reacted with a variety of other
species' spermatozoa.

This wide species-cross-reactivity

indicates shared antigens in these species and the possibil
ity of employing experimental animal models to test the use
of antigenic determinants recognized by these MAbs as birth
control vaccines.

Such a finding is reasonable in light of

other investigators' studies.

Lopo and Vacquir (1980) have
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reported that antisera against sea urchin sperm cross-react
with surfaces of sperm of 28 species from seven animal
phyla.

Other investigators have also detected the presence

of common sperm antigens among mammalian species by means of
MAbs (Feuchter et al. 1981; Gaunt, 1982).

They also ob

served cross-reactivity to mouse-, rat-, rabbit-, and guinea
pig sperm.

Analysis of antibody binding pattern in the IF

test indicated that segregation of similar sperm-specific
antigenic determinants into identical domains in the tested
species might be related to some common sperm function.

One

such sperm antigen is testis-specific lactate dehydrogenase
(LDH-C4) which has been reported to be antigenically and
functionally similar in several mammalian sperm (Erickson et
al., 1975).

However, it should kept in mind that MAbs

recognize only a region of a particular molecule.

It is

therefore possible that other parts of the surface compo
nents recognized by the cross-reacting MAbs may differ among
the species, thus altering the function of these components.
When these monoclonals were tested on fresh, capacitat
ed, and acrosome reacted spermatozoa, DH22 showed differen
tial reactivity with swim-up sperm as compared to Ca++
ionophore treated sperm (acrosome reacted) in ELISA.

This

finding suggests that changes in the recognition of sperma
tozoa surface antigens during capacitation allowed increased
or shifted antigen expression.

The pattern of antibody

binding to the sperm also changed.

It reacted heavily with
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acrosomal region on acrosome reacted sperm.

Primakoff et

al., (1988) also reported an antigen, PH-20, localized on
both plasma membrane and inner-acrosomal membrane depending
on the sperm status.

Before the acrosome reaction, this

antigen was localized to the posterior head surface of the
sperm.

After the acrosome reaction, however, PH-20 migrates

from the posterior head surface onto the inner acrosomal
membrane and this migration increases the total amount of
PH-20 protein on the sperm surface approximately threefold.
Further studies on antigen migration or unmasking would be
useful for DH22.

Since DH22 showed a brighter binding by IF

to acrosomal cap region of acrosome reacted sperm, this MAb
can be used as a marker to identify acrosome reacted sperm
among the different stages of sperm population.

When our

antibodies were compared with fresh (noncapacitated) and
capacitated sperm, changes in surface composition were not
observed as sperm under capacitation since antigens were
equally detectable on fresh and capacitated sperm, which
probably suggests that these monoclonals recognize antigens
common to both fresh and capacitated spermatozoa.
Immunoblot analysis indicated that most of our anti
sperm MAbs reacted against sperm membrane proteins ranging
from 14 to

68

KD molecular weight.

Primakoff and Myles

(1983) reported guinea pig sperm head antigens ranging from
18 to 70 KD.

These results may indicate that proteins

within this molecular weight range are commonly associated
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with sperm plasma membrane.

Isahakia and Alexander (1984)

reported a mouse antihuman sperm MAb, MA3, that reacted
against human sperm acrosomal antigen with >200 KD.

MA3

showed inhibition of sperm functional assay (agglutination
and immobilization). Saling (1985) also reported an anti
sperm MAb, M42, which significantly inhibited mouse fertil
ization in vitro.

This M42 also recognized a high molecular

weight doublet, 220-240KD, that was specific to spermatozoa.
In our study we also observed one MAb, DH13, that reacted
with post acrosome and tail region of human sperm, and
recognized a high molecular weight protein, >200 KD, however
it did not show any agglutinating or immobilizing properties
although it inhibited both the SPA and HZA.

Perhaps this

MAb is associated with sperm zona receptor or egg fusion
receptor.

Four antisperm MAbs that reacted with low and

medium molecular weight antigens associated with human sperm
have been reported by different authors, MA24, 20-35 KD (Naz
et al., 1984a), MA4, 20-35 KD (Isahakia and Alexander,
1984), C11H, 50-60 KD and 20-35 KD (Kallojoki and Suominen,
1984), and AF-1, 80-90 KD and <20 KD (O'Rand and Irins,
1984).

All of these were against human sperm except AF-1

which was against rabbit sperm antigen.

Among these AF-1

and MA-24 demonstrated inhibition of at least one sperm
functional assay.

In our study we also observed some MAbs

that reacted with low molecular weight proteins ranging 1437 KD.

Among these MAbs, DH3, DH4, DH21, DH22, DH201, DH202
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also inhibited at least one sperm functional assay.

Some of

these MAbs also reacted with medium molecular weight protein
bands (50-68 KD) in addition of lower molecular weight
protein bands (14-45 KD). The WHO task force of antisperm
MAb provided limited data on the molecular weights of the
relevant antigens (Anderson et al. 1987).

Among those

antisperm MAbs identified for further investigation as
antifertility vaccine candidates, S20 (against testicular
germ cells and intraacrosomal cap) reacted with a low molec
ular weight protein ranged from 18-34 KD (Herr et al. 1991).
S20 inhibits sperm-egg interaction.

Lee et al. (1991)

reported two antisperm MAbs reactive against many mammalian
species' sperm acrosome.

MAb HS-11 recognized two polypep

tide bands in the 35-50 KD range and MAb HS-63 recognized 3
bands in the 42-50 KD range.

Both HS-11 and HS-63 inhibited

sperm-egg interaction in mouse in vitro.

In our study MAb

DH3 reacted with the acrosome, neck, and tail region of
human sperm and recognized 14, 25, and

68

KD protein bands.

DH 22 reacted with an intraacrosomal protein and recognized
14 and

68

KD bands.

Both DH3 and DH22 inhibited sperm/

hamster egg interaction and human zona binding.

Comparison

of the data from the WHO report (Anderson et al. 1987) with
that of our study, it seems as if many lower molecular
weight proteins are associated with sperm-egg interaction
but some medium and high molecular wight proteins also can
participate.

It is not surprising that a MAb raised against
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a given antigen can give multiple bands.

These results can

indicate that a MAb could share some common antigenic epi
topes of different proteins involved with different sperm
functions.

Moreover, SDS can cause breakage to molecules

thus antigens can be of reduced size in SDS, i.e., 48 KD and
a 24 KD molecule could indicate such a phenomenon.
our MAb DH21 recognized five bands,
KD.

68

One of

, 45, 37, 23, and 14

Here 45 KD band might reduced in size and produced

another band of 23 KD.
nonreducing gels.

This can further studied by using

Perhaps purification and a more detailed

biochemical characterization of these antigens are necessary
to illustrate more information.
Employing hybridoma technology, monoclonal antibodies
developed against human spermatozoa have demonstrated the
multiplicity of the antigens having a role in the process of
fertilization.

We found that MAbs, DH3, DH13, DH14, DH22,

and DHT0 IP3C9 , significantly inhibited the standard sperm
penetration assay (SPA) that has been used in most investi
gations of mammalian sperm-egg fusion.

Among our antisperm

MAbs DH3 and DH13 showed inhibition only when they were
treated with precapacitated spermatozoa but not with
postcapacitated spermatozoa.

These results support the

hypothesis that antibody directed against the plasma mem
brane of sperm can affect the mobility of membrane
particles, thus impeding or possibly hastening capacitation
and the acrosome reaction process necessary for sperm-egg
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fusion.

Another possibility would be that these antigens

coated sperm in epididymis but were removed during capacita
tion so these MAbs did not inhibit SPA when treated with
postcapacitated sperm.

Other researchers also reported

(Alexander 1988) that some antisperm monoclonal antibodies
can prevent sperm fusion with hamster eggs when exposed to
precapacitated human spermatozoa.

Although some researchers

suggested that the sperm acrosomal region is the most potent
for egg binding and penetration, Naz and associates (1984)
and Primakoff et al. (1987) reported that MAbs binding to
the post-acrosome and tail can also block binding and pene
tration of zona-free hamster eggs by sperm.

In our study we

developed two MAbs (DH13 and DHF5) that recognized the postacrosomal and tail regions on sperm and did inhibit spermegg fusion.

DH3 was found to react to the acrosome, tail

and neck regions on human sperm, as well as to significantly
inhibit hamster egg penetration by human spermatozoa (SPA).
This result suggests that the sperm post-acrosome and tail
regions are composed of multiple antigens that may have
different sperm functions in the fertilization process.

MAb

DH22 showed strong inhibition when post-capacitated sperm
was incubated with this Mab.

This result supports our

previous finding that DH22 strongly reacted with acrosomereacted sperm, particularly on the acrosomal region of
sperm.

DH22 moderately reacted with the equatorial region

with pre-capacitated and capacitated sperm.

Sperm that are
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capable of fusing with eggs are apparently acrosomereacted
(Yanagimachi, 1981).

Some laboratories have also reported

that the equatorial region of the plasma membrane may also
be involved in sperm-egg fusion (for review, Yanagimachi,
1981) . Our study supports this concept because DH22 reacted
with the equatorial region and showed some inhibition of
sperm-egg fusion with precapacitated sperm.
The hemizona assay (HZA) was used to measure the effi
ciency of sperm function to achieve tight binding to the
zona pellucida in the presence of these MAbs.

Use of NS-1

as a control ascites fluid demonstrated that peritoneal
fluid proteins did not interfere with the sperm-zona inter
actions.

Use of Fab fragments with the HZA was employed to

answer any lingering question regarding the effects of
agglutination.

The initial screening procedure used here

permits the evaluation of large numbers of Mabs.

Those that

are found to have shown some inhibitory effects can be
evaluated extensively at a later date.

Additional studies

could be done including the antibody dose dependency, the
removal of excess antibodies and other components (Mahony et
al., 1990).

Seven of our antisperm MAbs (DH3, DH4, DH13,

DH14, DH21, DHTB11, and DH205) impeded the HZA; all were
against coating antigens.

MAbs DH4, 21, TB11, and 205 did

affect sperm performance in the HZA but did not affect the
SPA.

These results support our previous findings that these

corresponding antigens are available only during the process
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of capacitation but are unrecognizable or absent from sperm
head once the sperm are predominately acrosome reacted.
These MAbs may be specific for a portion of the zona binding
receptor.

Such antibodies are thought to reduce zona bind

ing of sperm by obscuring the receptor site/steric hindrance
(Singer et al., 1985; Alexander, 1990).

MAbs DH3 and DH13

strikingly impeded HZA binding as well as decreased the SPA
when precapacitated sperm were used.

These results indicate

that these MAbs may be covering a portion of the receptor
involveed in zona binding; sperm penetration can be inhib
ited by preventing the acrosome reaction as capacitation
occurrs.

However, the SPA assesses other events i.e.,

sperm-egg fusion and decondensation of nuclear material in
addition to the ability to spontaneously acrosome react over
time.
Cervical mucus (CM) penetration is another important
sperm function known to be inhibited by sperm antibodies
(Fjallbrant, 1969).

Kremer (1982), Hendry et al (1982), and

Clarke (1988) reported that only sperm bound antibodies of
IgA class are associated with poor CM penetration in vitro,
but sperm bound IgG class antibodies do not appear to be
associated with poor CM penetration.

Sperm surface IgA

class immunoglobulins adhere to the glycoproteins of the
cervical mucus and impair sperm penetration (Kremer and
Jager, 1980).

Wang et al. (1985) reported that, in the

presence of sperm, surface tail-tip antibodies of either IgA
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and IgG classes did not interfere with sperm penetration of
human cervical mucus.

Therefore, we can assume that proba

bly both the immunoglobulin class and the region of binding
on sperm are important in determining the degree of impair
ment of fertility in men with sperm antibodies.

All of our

fifteen MAbs were either IgM or IgG class, and none of these
Mabs showed any inhibition of CM penetration.
When periodic acid treated sperm were used for ELISA,
result showed that binding of MAbs DH200 and DH202 to sperm
surface antigens was inhibited severely, and DH203 inhibited
binding moderately, suggesting that these sperm antigens may
be composed of carbohydrate as a major moiety, and peptide
as a minor moiety.

Isojima et al. (1990) reported three

MAbs (H6-3c4, 2B6, and 2E5) against human sperm coating
antigens. The antigenicity was completely destroyed by
treating with periodate, but the antigenicity to MAbs 2C6
was retained in some degree compared to other MAbs.

Their

suggestion was the antigenic epitope of MAbs H6-4C4 may be
glycolipid, but that of MAb 2C6 may be composed of carbohy
drate and peptide as major and minor moieties, respectively.
Other researchers from our laboratory have also reported
that some complex carbohydrate antigens are associated with
the sperm cell surface (Kurpisz et al., 1989).
Studies

of a few female sera (Ingerslev, 1979; Isojima

et al., 1972) have revealed that sperm-agglutinating
antibodies and sperm-immobilizing antibodies can be either
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of the IgM- or the IgG-class, although the majority of sperm
immobilizing antibodies belong to the IgG class (Isojima,
1989).

All our sperm agglutinating MAbs belonged to the IgG

class, as did our three immobilizing MAbs.

Since sperm

SA/SI antibodies in patients and experimental animals are
polyclonal antibodies, production of monoclonal antibodies
with SA/SI activities is essential to analyze the antigenic
epitopes of corresponding antigens.

In 1980, Isojima et

al., reported a rat-mouse heterohybridoma, IC4, against
human seminal plasma which secreted a strong SI-Mab.

But

this antigen does not seem to be a good candidate for immu
nological contraception because the antigenicity is shared
with human milk protein.

The Isojima group also produced

some mouse MAbs possessing SA- and Sl-activities, but all
were human seminal plasma antigen specific.

In our study

none of the four MAbs with SA- and SI- activities reacted
with human seminal plasma, but did react with sperm membrane
integral antigen.

So, they are against a sperm membrane

integral antigen rather than sperm coating antigen originat
ing from seminal plasma.
The absence of cross-reactivity to somatic tissues
coupled with inhibition of at least one sperm functional
test by antisperm surface antibodies sperm is one of the
important criteria of a primary candidate for contraceptive
vaccine development as established by the WHO in a
Monoclonal Antibody Workshop (Anderson et al., 1987).

Eight
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of our monoclonal antisperm antibodies were able to inhibit
at least one in vitro sperm functional test and showed no
cross reactivity with human somatic tissues.

Further puri

fication of these antigens and analyzation of the antigenic
epitopes and biochemical characterization would be of inter
est to better understand their immunocontraceptive poten
tial.
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CHAPTER 8

CONCLUSIONS

1.

NP-40 detergent can extract surface protein (both
coating and integral) from sperm membrane.

Using this

extracted protein as immunogen is a successful approach
to produce sperm surface-specific monoclonal antibodies.

2.

We have developed one hundred thirty monoclonal
antisperm antibodies and, among these, fifteen have been
characterized.

These fifteen do not cross-react with

human somatic cells but react with sperm and germinal
cell components of the male reproductive system,
indicating their sperm specificity.

This fulfills one

of the important criteria for contraceptive vaccine use
reported by the WHO Monoclonal Antibody Workshop.

Four

of our MAbs are reactive to epididymal factors, three
are reactive to seminal vesicle factors, and seven
are reactive to testicular factors.

3.

Eight of our monoclonal antisperm antibodies were able
to inhibit at least one in vitro sperm functional test
which also meets another criteria of immunocontraception.

These MAbs can be used to isolate sperm
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antigens for biochemical characterization or can be used
for cDNA testis libraries for production of sperm
membrane antigens to better understand their immunocontraceptive potential.

4.

MAbs against a coating antigen affected the in vitro
sperm penetration assay suggesting importance of sperm
surface interaction with the egg and egg vestments.

5.

Since a significant number of women with infertility of
undetermined etiology have elevated titers of antisperm
antibodies capable of inducing sperm agglutination or
immobilization in their sera and cervical fluids, MAbs
DH200-203 (sperm agglutinating and/or immobilizing
antibodies) can be used for corresponding antigen
isolation and biochemical characterization to better
understand their role in immunocontraception.

6

. Since one MAb (DH22) is capable of binding to
the acrosomal cap region of acrosome reacted sperm, this
MAb can be used as a marker to identify acrosomal react
ed sperm among the different stages of sperm population.
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TABLE A

Spermatozoa! Auto- and Iso-Antigen

Antigens

Localization and Characterization of Antigen

Membrane
antigens

Two glycoproteins, widely
distributed in the membrane.
One antigen restricted to the tail
end piece.

Sperm-specific
enzymes
LDH-C4

In the post-acrosomal area of the
plasma membrane and in seminal
plasma.

acrosxn

In acrosome, including equatorial
segment.

hyaluronidase

In acrosome.

DNA polymerase

In nucleus and seminal plasma.

Nuclear proteins

Protamine l and 2 in sperm nucleus

Various subsurface
antigens, characterized
mainly by their location

In acrosome, equatorial segment,
postnuclear area, main tail piece,
and tail end piece.
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